Characterization of the molecular basis underlying the subversion of dendritic cells homoeostasis by implantable biomaterials by Shokouhi, Behnaz
Characterization of the Molecular Basis
Underlying the Subversion of Dendritic
Cells Homoeostasis by Implantable
Biomaterials
Von der Fakultät für Mathematik, Informatik und
Naturwissenschaften der RWTH Aachen University zur
Erlangung des akademischen Grades einer Doktorin der
Naturwissenschaften genehmigte Dissertation
vorgelegt von
M.Sc. Behnaz Shokouhi
aus Mashad, Iran
Berichter:
Universitätsprofessor Dr. Martin Zenke
Universitätsprofessor Dr. Lothar Elling
Tag der mündlichen Prüfung: 15.02.2011
Diese Dissertation ist auf den Internetseiten der Hochschulbibliothek online verfgbar
iThanks to the grace of God who has always watched me through
ups and downs of my life and brought me here.

iii
To
The ones who honored me by sharing their spiritual or scientific knowledge
and
The ones in the most remote corners of the world who never had a chance of
education.

vAcknowledgments
This dissertation would not have been possible without the guidance and the
help of several individuals who in one way or another contributed and ex-
tended their valuable assistance in the preparation and completion of this
study.
I am very grateful to Prof. Martin Zenke for giving me the opportunity to be
a member of his lab and for his scientific support and encouragement during
my Ph.D.
My sincere appreciations go to my supervisor Dr. Antonio Sechi who has
been always there for me and supported me in every possible way. I have
always admired his genuine dedication to scientific research and his critical
and thought-provoking approach to this study.
I am deeply indebted to Prof. Shizuo Akira at Osaka University, for gener-
ously hosting me in his lab during our collaboration, Prof. Cevayir Coban for
supervising me during this time, Prof. Ken J. Ishii, Drs. Shohei Koyama and
Taiki Aoshi for their scientific insights.
I very much appreciate Prof. Vasif Hasirci and Dr. Erkin Aydin at Ankara
University for their contribution to this study.
I would like to thank Prof. Willi Jahnen-Dechent and Prof. Lothar Elling for
being a part of my Ph.D commission and for their insightful comments.
vi
I thank Jochen Salber and Anandhan Dhanasingh at DWI e.V and Institute
of Textile and Macromolecular Chemistry, RWTH Aachen for providing bio-
materials used in this study.
I am thankful to all members of the Cell Biology lab for their help and the
time we shared inside and outside the Klinikum. In particular, I thank Chris,
Saskia, Sigrid, Bärbel, Nadine, Gülcan and Paul for making the lab go around
over these years and Daivd and Qiong for the Mac support. Thank you Qiong
for helping me with the Latex.
Many thanks to the people in IZKF-Biomat, Animal Facility, Apotheke and
Institute of Pathology for helping me beyond their obligations.
I would like to express my gratitude to my parents for their love and encourage-
ment and the rest of my family and friends for their care and understanding.
In particular, I am thankful to Hanieh, Marc, Forough, Chris, Christine and
Saskia for making my life in Aachen enjoyable.
And last but not least, my deepest love and appreciations belong to Pooria for
being so present in every moment of my life despite the thousands kilometers
of distance.
vii
The work described in this thesis resulted in the following publications:
Papers:
Shokouhi B., Coban C., Hasirci V., Aydin E., Dhanasingh A., Shi N., Akira
S., Zenke M. and Sechi A.S. The role of multiple Toll-like receptor signalling
cascades on interactions between biomedical polymers and dendritic cells. Bio-
materials (2010) 31(22): 5759-71.
Posters:
Shokouhi B., Salber J., Shi N., Zenke M., Sechi A.S. Biomaterials cause den-
dritic cell malfunction by impinging on TLR-MyD88 signalling pathways: Im-
plications for in vivo Implant failure. Tag der Medizinische Forschung- De-
cember 11th 2009. RWTH Medical Faculty Aachen, Germany.
Behnaz Shokouhi, Jochen Salber, Anandhan Dhanasingh, Martin Zenke and
Antonio S. Sechi. 41. Jahrestagung der DGBMT - Deutschen Gesellschaft für
Biomedizinische Technik (ARAC, Aachen, 26-29th September 2007).
Shokouhi B., Salber J., Dhanasingh A., Shi N., Zenke M., Sechi A.S. In-
fluence of biomaterials on essential dendritic cell function. Kerkrade, The
Netherlands, 28-29th March 2007.
Shokouhi B., Salber J., Dhanasingh A., Shi N., Zenke M., Sechi A.S. Influence
of biomaterials on essential dendritic cell function. 9th International Confer-
ence of Dendritic Cells, Edinburg, Scotland, 16-20th September 2006.
Talks:
B. Shokouhi, C. Coban, A. Dhanasingh, N. Shi, S. Akira, M. Zenke and A.S.
Sechi. Biomaterials cause dendritic cell malfunction by impinging on TLR-
MyD88 signaling pathways: implications for in vivo implant failure, “Winter
School on Frontiers in Nanomedicine and Nanobiotechnology” and “Workshop
on Current Trends in Molecular Nanobiosciences”, Ankara-Turkey. 10-16th
January 2010.
Shokouhi B., Coban C., Dhanasingh A., Salber J., Akira S., Zenke M., Sechi
A.S. Characterization of the molecular basis of the subversion of dendritic
cell homeostasis by implantable biomaterials, 22nd European Conference on
biomaterials, Lausanne, Switzerland, September 7-11th 2009.
Prizes:
IZKF-BioMAT best poster prize in “Der Tag der Medizinische Forschung”
(Day of Medical Research), Aachen, December 2009.
1Abstract:
In modern medicine, biomaterials are used in several medical applications
ranging from tissue regeneration to antigen-delivery systems. Despite the
widespread use of biomaterials, the reaction of the host immune system against
implants still constitutes a problem sometime causing implant failure. Thus,
there is a major need to understand how biomaterials interact with the im-
mune cells.
Dendritic cells (DCs) are the specialized antigen-presenting cells that have
the unique ability to sense intruding pathogens, activate naïve antigen-specific
T cells and regulate immunological responses. In this study, I have analyzed
the molecular interactions between chemically and physically diverse bioma-
terials and DCs using several murine knockout systems. I found that DCs
could sense biomedical polymers through a mechanism, which involves multi-
ple TLR/MyD88-dependent signalling pathways, in particular TLR2, TLR4
and TLR6. TLR-biomaterial interactions induce the expression of activa-
tion markers and pro-inflammatory cytokines and are sufficient to confer on
DCs the ability to activate antigen-specific T cells. This takes place through
direct biomaterial-DC interactions although, for degradable biomaterials, sol-
uble polymer molecules can also alter DC function. Finally, the engagement
of TLRs by biomaterials profoundly alters DC adhesive properties.
These findings should be useful for designing structure-function studies
aimed at developing more bio-inert materials. Moreover, given the major role
of TLR2, TLR4 and TLR6 in the alteration of DC functions by biomaterials
shown in this work, I also envisage the possibility to design biomaterials that
specifically activate TLR2 or TLR4 to achieve antigen-specific TH1- or TH2-
type immune responses, respectively.
2Zusammenfassung:
In der modernen Medizin werden Biomaterialien in verschiedenen medizinis-
chen Applikationen verwendet, von Geweberegeneration bis hin zu Antikörper-
Transport Systemen. Obwohl Biomaterialien bereits vielseitige Verwendung
finden, ist die Reaktion des Immunsystems des Patienten auf das Implantat,
welche zu einer Abstoßreaktion führen kann, immer noch ein Problem. Daher
ist es von äußerster Wichtigkeit zu verstehen, wie Biomaterialien mit dem
Immunsystem interagieren.
Dendritische Zellen (DCs) sind spezialisierte Antigen-präsentierende Zellen,
welche die einmalige Eigenschaft besitzen, eindringende Pathogene zu lokalisie-
ren, naïve Antigen-spezifische T-Zellen zu aktivieren und immunologische
Antworten zu regulieren. In dieser Studie habe ich, durch die Verwendung
verschiedener Maus-Knockout-Systeme, die molekularen Interaktionen zwis-
chen chemisch und physikalisch unterschiedlichen Biomaterialien und DCs un-
tersucht.
Ich habe gefunden, dass DCs biomedizinische Polymere mit einem Mecha-
nismus erkennen können, der vielfältige TLR/MyD88-abhängige Signalisieru-
ngswege, im Besonderen TLR2, TLR4 und TLR6, benutzt. Interaktionen
zwischen TLR und Biomaterial induzieren die Expression von Aktivierungs-
markern und frühen Entzündungszytokinen und sind ausreichend, die Fähigkeit
von DCs, Antigen-spezifische T-Zellen zu aktivieren, zu sichern.
Dies trifft auch für die direkte Interaktion zwischen Biomaterial und DCs
zu, während bei degradierbaren Biomaterialien, lösliche Polymer-Moleküle die
DC Funktion auch verändern können. Desweiteren verändert die Mitwirkung
der TLRs bei den Biomaterialien hochgradig die adhäsiven Eigenschaften der
DCs. Diese Resultate könnten nützlich sein bei der Entwicklung von Struktur-
3Funktionsstudien, die daraufhin ausgerichtet sind, bessere bioverträgliche Ma-
terialien zu finden. Ferner könnte man möglicherweise Biomaterialien entwick-
eln, die entweder spezifisch TLR2 oder TLR4 aktivieren, um eine Antigen-
spezifische TH1- oder TH2-Typ Immunreaktion zu erzielen.
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Chapter 1
Introduction
1.1 Historical view of biomaterial applications
in medicine
By definition, biomaterials are materials used in different medical-related
fields, which ultimately come into close contact with the body tissues, usually
in the form of implants (Williams, 1987).
The practice of prosthetic devices stretches as far back as thousands of
years in human history. The very first use of non-biological materials can
be traced back to 32.000 years ago, when sutures were used for large wound
closure by early civilizations (NATNEWS, 1983). The Indian sacred text Rig
Veda, written between 3500-1800 BC, provides the earliest documented ev-
idence of prosthesis application. It reveals the story of the Warrior-Queen
Vishpla who lost her leg in a fight, had it replaced with a fabricated iron leg
and returned to the battlefield (Nebit, 2004). Additional evidences suggest
that early Egyptians were familiar with the knowledge of manufacturing artifi-
cial devices. Prostheses were not only applied to improve function of damaged
organs, but also in favor of psycho-spiritual sense of wholeness for the eternal
life. For ancient Egyptians it was essential to have an intact physical body to
be able to begin the next life after death (Thurston, 2007).
Discovery of an Egyptian mummy with toe prosthesis illustrates one of the
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earliest prosthesis applications in the history back to 1500 BC. In this case,
the amputated toe of a 50-60 year old woman was replaced by a wooden pros-
thesis, allowing her to walk without major restrictions (Figure 1.1; Nerlich et
al., 2000).
Figure 1.1: Views of the right foot with amputated toe and the prosthesis replacing it.
A, Radiograph of foot bones showing the missing toe. B, Wooden prosthesis attached to
the forefoot by a textile lace (Nerlich et al., 2000).
In the era of prehistory and for a quite long time afterwards, most of the
implantations had a low chance of success. The reasons for these failures
were, of course, the poor understanding of implant-body interactions, the
intrinsic nature of the biomaterials and the lack of sterilization. Over time,
advancements in the fields of biology, physics and chemistry have led to novel
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regulations and approval processes to minimize the risk of implant failure. In
this context, the characterization of features contributing to implant-tissue
interactions resulted in manufacturing more biocompatible biomaterials.
Today a large variety of implants and prostheses including pacemakers,
artificial joints, breast implants, heart valves and stents has been developed
and applied to treat different pathological conditions.
1.2 Biocompatibility
Although biocompatibility has been the central theme and main concern in the
design and application of biomedical devices, there is still no precise definition
of this term. The word biocompatibility embodies broad characteristics of a
material. According to a generally accepted definition:
biocompatibility is defined not only by the lack of cytotoxicity of
the biomaterial, but also by the biomaterial’s biofunctionality. The
latter supports cell-biomaterial interactions according to local and
organ specific situations where the biomaterial is applied (Rickert
et al., 2006).
In simple words biocompatibility of a device can be collectively determined
by the degree of its biosafety and biofunctionality (Schoen and Anderson,
2004; Williams, 2009). Several factors can influence the biocompatibility of an
implant, though four parameters mostly affect it: i) physico-chemical features
of the biopolymer, ii) patient’s characteristics, iii) implantation site and iv)
the duration of the implantation (Kato et al., 2000). These different aspects
are briefly discussed below.
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1.2.1 Effect of surface physico-chemical properties on
material biocompatibility
The physico-chemical properties of implant’s surface are key elements in de-
termining the extent and severity of biomaterial-induced immunological reac-
tions. In this context, it has been shown that the molecular architecture of the
surface or its topography determines the direction of cell migration, cell adhe-
sion and also affects the cellular response to biomaterials in vivo and in vitro
(Puleo and Nanci, 1999; Brunnette, 1988; Schmidt and von Recum, 1991).
Additional studies have shown the effect of micro topography of different bio-
materials including PLGA [poly(lactic-co-glycolic acid)] on cell adhesion and
directional cell migration (Brunette, 1988; Ranucci and Moghe, 2001).
The degree of biocompatibility can also be affected by the conformational
structure and flexibility of the biomaterial molecule (Fischer et al., 2003).
More precisely, it has been shown that branched cationic molecules are able
to neutralize the cell surface’s charge more efficiently than linear or globular
structures (Choksakulnimitr et al., 1995). Moreover, globular polycations
cause less cell damage than linear and branched molecules like poly(L-lysine)
(Fischer et al., 2003).
Usually, the surface of natural molecules such as proteins can be either
positively or negatively charged. As a consequence, they will tend to inter-
act with molecules or materials carrying the opposite charge. For instance,
negatively-charged proteins will adhere to positively-charged surfaces. Hence,
polycations such as poly(L-lysine) are able to induce more cellular damage in
different cell types (Strausbaugh, 1987; Horrow, 1985; Broestl and Emancipa-
tor, 1993). There are evidences that polycations induce a high LDH (lactate
de-hydrogenase) release and severe morphological alterations in different cell
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types (Choksakulnimitr et al., 1995). Furthermore, free functional groups in
polymeric structures can influence the biocompatibility of the implant and
affect its therapeutic nature (Jagur-Grodzinski, 1999). Investigations have
shown that different functional groups can inhibit or enhance diverse biologi-
cal activities. For instance, it has been demonstrated that negatively-charged
carboxylate groups have an inhibitory effect on the activation of the comple-
ment cascade in the body (Chenoweth, 1987).
Based on their origin, biomaterials can be categorized into two main
groups; biomaterials from natural sources such as: cellulose, chitosan or algi-
nate, and synthetic biomaterials like: PTFE, PVDF, PET (Figures 5.1 and
5.2 in the appendix), different metals and ceramics. In addition, biomateri-
als can be either degradable or non-degradable. If a biomaterial undergoes
degradation, new by-product molecules with different molecular weight and
functional groups are produced which may also affect the reaction of the host
to the implant as discussed above.
Several investigations have shown that the molecular weight can influence
the cytotoxicity of polymers with the same chemical structure. For instance,
Fischer (Fischer et al. 2003) and others have shown that the molecular weight
of DEAE-dextran (diethylaminoethyl-dextran) influences the metabolic activ-
ity of mouse fibroblasts. Precisely, DEAE-dextran with higher molecular size
was associated with higher cytotoxicity. A similar behavior has also been
observed for poly(L-lysine) and poly(ethylenimine) (PEI; Choksakulnimitr et
al., 1995; Fischer et al., 1999).
In general, hydrophobic surfaces have a higher tendency to adsorb proteins
than hydrophilic ones, thus, medical devices with a hydrophilic surface should
be expected to be more biocompatible (Elbert and Hubbell, 1996; Akaike
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et al., 1997). In agreement with this notion, in vivo studies have demon-
strated the inhibitory effect of hydrophilic coating on thrombus formation of
polyurethane catheters as compared to uncoated ones (Nagaoka and Akashi,
1990). In the context of the immune reaction against an implant, it is impor-
tant to point out that hydrophobic and anionic surfaces usually promote an
anti-inflammatory response and induce apoptosis for instance in macrophages
(Brodbeck et al., 2002a; Brodbeck et al., 2002b). To achieve an optimal
application-specific protein adsorption researchers suggest a balance between
hydrophobic and hydrophilic surface characters.
1.3 Host-implant interactions
Host-implant interactions are complex and not fully understood. Within min-
utes after the implantation, the contact of the implant with body extracellular
fluids and tissues immediately triggers an inflammatory reaction that overlaps
with the physiological one that accompanies the wound healing.
Over time, these interactions ultimately affect the characteristics and func-
tion of both implant and patient. Therefore, understanding the first interac-
tions between the host and the biomaterial is crucial to control the outcome
of the implantation and to avoid health complications of the patient.
1.3.1 Cell attachment to the substrate
Upon placing a biomaterial in the body, plasma proteins and cells adjacent the
implantation site adhere to the implant’s surface. Cells can sense, distinguish
and respond differentially to distinct implant features such as chemistry, stiff-
ness and topography at macro and nano scale (Anderson et al., 1995; Chen
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et al., 1997; Dalby et al., 2002).
These elements highly influence cell attachment to the surface that can
occur via the assembly of either focal adhesions or podosomes. Podosomes are
formed by few cell types, mainly osteoclasts, macrophages and DCs (Linder
and Aepfelbacher, 2003), whereas focal adhesions can be observed in almost
all kind of cells. Although focal adhesions and podosomes have a similar
molecular composition, they are different in terms of architecture, function
and dynamics (Block et al., 2008). Podosomes have a roughly circular shape
with a diameter of 0.5 µm and consist of an F-actin-rich core surrounded by a
ring containing mainly talin and vinculin. The architecture of focal adhesions
(FAs) that is considered to be the strongest type of adhesion, is more complex
and centered on transmembrane proteins called integrins (Chen and Singer,
1982; Burridge et al., 1988; Schwarz et al., 1995). Talin is also a component of
FAs and plays a crucial role in the formation and dynamics of these structures
as indicated by the fact that talin-negative cells lose the ability to form FAs
(Zhang et al., 2008).
The interaction between cell and material surface is a complex phenomenon
and at least 50 proteins have been found to be involved in cell-substrate ad-
hesion process (Zamir and Geiger, 2001). Substrate properties not only affect
the attachment patterns, but also dramatically influence other cell charac-
teristics such as morphology, dynamics, behavior, differentiation and death
(Feser et al., 2010; Geiger et al., 2009; von Recum and van Kooten, 1995;
Wang et al., 2004). Therefore, understanding the interaction between cells
and material surface is crucial for the design of function-specific biomaterials.
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1.3.2 Foreign body reaction and fibrosis
As elaborated above, immediately upon implantation, proteins are adsorbed
onto the surface of biomaterial. The attachment of the cells to the protein
layer initiates a cascade of inflammatory reactions including blood coagulation
and the recruitment of monocytes and macrophages (Anderson, 2001). These
leukocytes secret cytokines, recruit other cells and fuse with each other to form
foreign body giant cells (FBGCs), ultimately resulting in the formation of a
fibrotic capsule around the implant (Anderson et al., 2008; Xia and Triffitt,
2006; Jones et al., 2007; Hernandez-Pando et al., 2000).
The formation and dynamics of FBGCs is a complex phenomenon involv-
ing different cell types, receptors and cytokines. Most of the studies in this
field have been focused on the role of neutrophils and macrophages in re-
sponse to a foreign material including both particulate and dissolved salt of
metals (Caicedo et al., 2009; Tang and Hu, 2005). Macrophages are mem-
bers of antigen presenting cells (APCs), capable of engulfing and degrading
microbes and synthetic molecules by different means, in particular by produc-
tion of reactive oxygen species (Ward, 2008). Macrophages secret cytokines,
which are involved in the formation of multinucleated giant cells. It has been
shown that upon implantation, macrophages initially secret pro-inflammatory
cytokines such as IL-1β and IL-6 but, as the situation evolves, they mainly
produce the anti-inflammatory cytokine IL-10 (Jones, 2008). For instance, ul-
tra high molecular weight polyethylene (UHMWPE) stimulates macrophages
to secrete TNFα and IL-1β (Garrigues et al., 2005).
Concerning the neutrophils, many studies have shown that various biopoly-
mers including PTFE, polyurethane and Dacron induce in these cells the re-
lease of superoxide (Kaplan et al., 1994; Kaplan et al., 1996; Moore et al.,
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2001; Patel et al., 2007; Santos et al., 2007).
Several plasma membrane receptors have been implicated in the formation
of FBGCs. Apart from integrins, other plasma membrane proteins have been
shown to be involved in biomaterial-cell interaction and FBGCs formation
(Tang and Eaton, 1993; McNally and Anderson, 1994). For instance, the DC
specific trans-membrane protein DC-STAMP, which is expressed in DCs and
macrophages, has been shown to be necessary for cell-cell fusion and formation
of FBGCs structures (Yagi et al., 2005; Yagi et al., 2007; Eleveld-Trancikova,
2005). Other studies have implicated the essential role of fusion-mediators
connexin 43 and E-cadherin in this process (Brodbeck and Anderson, 2009).
Concerning soluble cellular factors, the cytokines IL-13 and IL-4 were
found to be involved in the process of macrophages fusion. As a possible
mechanism it was proposed that these cytokines up-regulate the mannose re-
ceptors at the fusion site. This notion is supported by the observation that
the inhibition of mannose receptor activity leads to a reduction of macrophage
fusion (McNally et al., 1996). Several studies revealed that in the foreign body
capsule (FBC) secretion of TGFβ-I and II is up-regulated and subsequently
formation of type I collagen, the downstream target of the TGFβ, is enhanced
(Li et al., 2007).
Formation of FBGCs provides a microenvironment between biomaterial
surface and cell membrane in which different degradation mediators such as
reactive oxygen intermediates (ROIs), oxygen free radicals, degradative en-
zymes and acids can be released (Henson, 1971a; Henson, 1971b). This, re-
sults in reduction of the pH of the environment and might lead, depending on
the chemical nature of the biomaterial, to surface degradation (Haas, 2007).
Notably, under certain conditions the accumulation of released degradation
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by-products in the body might lead to local or systemic toxicity (Hensten-
Pettersen and Jacobsen, 2004). Some polymers, such as polylactic acid,
polyglycolic acid and polycarbolactone can undergo this type of degradation
and monomeric units of these polymers can be degraded in the Kreb’s cycle
(Tokiwa and Calabia, 2006).
The intensity of the foreign body reaction depends on different parameters,
including contact durability, degradation rate, shape, morphology, porosity,
roughness, size and the implantation site (Arshady, 2003; Morais et al., 2010).
1.3.3 Impact of the host on biomaterial properties
As mentioned earlier, not only the implant affects the host and its function,
but the host also influences the implant’s performance at different levels.
These effects can range from fatigue, stress corrosion, cracking, degenera-
tion and dissolution to calcification, enzymatic degradation or absorption of
substances, including body fluid from tissues (Onuki et al., 2008: Anderson
and Langone, 1999).
The extent and the intensity of these effects are determined by the size,
shape and physico-chemical properties of the biopolymer as well as by the sur-
rounding tissue and targeted organ. Individual characteristics of the patient
are of great importance in determining the host-implant interactions. General
health condition, age, gender and lifestyle of the patient are critical factors
influencing the fate of the implant in the body (Williams, 2008; Dalu et al.,
2000; Da Silva et al., 1994).
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1.4 Post-implantation immunological reactions
The surgical manipulation as well as the implanted biomaterial can affect the
host’s homeostasis both locally and systemically. The implant-driven host
response may occur over short or long periods of time, resulting in acute
or chronic reactions, respectively. Regardless of patient responsiveness and
biomaterial physico-chemical properties, implantation may trigger one or more
of the following complications.
Infections have often been one of the major causes of implant rejection and
the main cause for morbidity and mortality (Jansen and Peters, 1993; Klug et
al., 1997). The infection process is usually triggered by bacterial adhesion on
the biomaterial surface and formation of highly antibiotic-resistant biofilms
(Pavithra and Doble, 2008). Implant-mediated infection cannot be controlled
by usual means and stays untreated until the device is explanted. Antibiotic-
resistant nature of the biofilms is due to the fact that they activate genes
that alter bacterial cell wall structure, which makes them less responsive to
antimicrobial drugs (Tenke et al., 2004; Anderson et al., 2004).
Moreover, constant exposure of the blood stream to biomaterial’s surface
and adherence of platelets to the implant as well as biomaterial-induced me-
chanical damage of blood vessels can lead to platelet activation and formation
of blood clots (Francos et al., 1983). As a consequence of mechanical and bio-
chemical stimuli, blood clots can detach and block downstream blood vessels,
causing thrombosis (Pavithra and Doble, 2008). Attempts have been made
to reduce the thrombogenicity of biomaterials by different means, including
coating the surface with anti-coagulating agents like heparin as well as incor-
porating a hydrophilic coating on the surface of the implants to make them
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more thromboresistant (Contreras et al., 2004; Nagaoka and Akashi,1990).
Furthermore, some studies have shown that despite being non-cytotoxic
the mere presence of certain biomaterials in the body results in tumor for-
mation though at rare incidence and usually over a long period of time post-
implantation (Anderson et al., 2004; Okada, 2007; Moizhess, 2008). Different
groups demonstrated that degradable poly-L-lactide and its copolymers and
non-degradable inert biomaterials, such as silicone and PE, can be genotoxic
causing the formation of tumors or chromosomal aberrations in both animals
and humans (Oppenheimer et al., 1955; Bischoff and Bryson, 1964; Turner et
al., 1941; Nakamura et al., 1994; Nakamura et al., 1998; Case et al., 1996).
Activation of macrophages upon surface attachment results in production
of pro-inflammatory cytokines as well as reactive nitrogen species (RNS) and
reactive oxygen species (ROS), which are highly genotoxic (Fulton and Love-
less, 1984; Kim et al., 2003; Kim et al., 2004; Dopp et al., 2005; Kawanishi
et al., 2002). Evidences indicate that implant’s physical properties play a
more important role rather than its chemical characteristics in this context.
Parameters, such as surface charge, surface area, hydrophobicity and rough-
ness, were shown to profoundly affect the carcinogenicity potential of the
implant (Brand, 1976; Carter et al., 1971; Bates and Klein, 1966; Moizhess
and Vasiliev, 1989).
1.5 Sensing machinery of the immune system
Survival of all living organisms depends on an effective defense strategy against
invasion of pathogenic microorganisms. The defense system in vertebrates
consists of innate and adaptive immunity. Antigen-unspecific innate immunity
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is the first and immediate response against invading organisms. Upon encoun-
tering pathogens, phagocytic cells, such as macrophages, neutrophils and DCs
are recruited to the site of infection and remove the pathogens by phagocytosis
or by secreting cytokines, which facilitate the elimination process. Adaptive
or acquired immunity is a slower immunological reaction mediated by pre-
senting antigen-derived molecules to T and B cells by antigen presenting cells
(Kawai and Akira, 2006; Akira and Takeda, 2004). B cells have the ability
to deactivate and neutralize pathogen-released toxins by secreting pathogen
specific antibodies, whereas T cells can eradicate pathogen-infected cells ei-
ther by cytotoxic effect or in collaboration with B cells (Hoebe and Janssen,
2004).
Pathogen detection and discrimination between self and non-self antigens
relies on the phylogenetically conserved pathogen sensors, known as pattern
recognition receptors (Janeway and Medzhitov, 1999; Aderem and Ulevitch,
2000). These receptors sense a broad-spectrum of microbial molecular motifs
known as pathogen-associated molecular patterns (PAMPs) as well as host
molecules released from dead or injured cells (Akira et al., 2006).
1.5.1 Pattern Recognition Receptors (PRRs)
Three families of extra and intracellular PRRs tightly regulate detection and
discrimination of invading microorganisms. The Toll-like receptors (TLRs),
the Nucleotide-binding and Oligomerization Domain (NOD)-Like Receptors
(NLRs) and the Retinoic acid-Inducible Gene I (RIG)-I Like Helicase Recep-
tors (RLHs) sense different PAMPs and modulate initiation of proper anti-
pathogenic response (Dostert et al., 2008). These receptor families and their
signaling pathways are illustrated in Figure 1.2.
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Figure 1.2: Illustration of pathogen recognition pathways and locations of distinct recep-
tors in the cells. TLRs, NLRs and RLHs collectively sense a broad range of pathogens.
Whereas extracellular pathogens are recognized by transmembrane TLRs, intracellular mi-
crobial signature and danger signals are detected by NLRs and RLHs (Ishii et al., 2008).
First discovered in Drosophila, the Toll protein was found also in immune
and non-immune cells, including fibroblast cells, epithelial and endothelial
cells of the vertebrates (Kumar et al., 2009). Each TLR recognizes its specific
ligand(s) and has a specific subcellular localization. TLR1, TLR2, TLR4,
TLR5, TLR6 and TLR11 are located on the cell surface, whereas TLR3,
TLR7, TLR8 and TLR9 are found in endosomal compartments (Figure 1.3;
Kumar et al., 2009; Gay and Gangloff, 2007). There are at least 13 TLRs
identified in human, and so far expression of TLR1-9, 11 and 13 has been
demonstrated in mice (Tabeta et al., 2004).
All TLRs signal through a cardinal adaptor protein called myeloid differen-
tiation primary response 88 (MyD88), except TLR3 which signals exclusively
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through the TIR-domain-containing adaptor inducing Interferon (TRIF) pro-
tein. TLR4, which mainly recognizes LPS, induces a dual signaling pathway
involving both MyD88 and TRIF (Shen et al., 2008; Kaisho and Akira, 2001).
In DCs, stimulation of TLRs activates transcriptional factors including NF-κB
which results in morphological alterations, increase of the phagocytic capa-
bility of DCs, along with up-regulation of co-stimulatory molecules and pro-
inflammatory cytokines (Akira, 2004; Akira et al., 2006; Takeda and Akira,
2005).
Figure 1.3: TLRs location and their natural ligands. Microbial wall products are usually
recognized by plasma membrane receptors TLR1, 2, 4, 5, 6 and 11, whereas their genetic
materials are sensed by TLR3, 7 and 9 located in the endosome. Except TLR3 which signals
via TRIF, all TLRs signal via MyD88 adaptor molecule (from Kumar et al., 2009).
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NLRs are the cytoplasmic counterparts of TLRs that recognize a set of
cytosolic PAMPs and endogenous ligands and induce the activation of NF-κB
in a TLR-independent manner (Fritz et al., 2006; Philpott et al., 2000; Ren et
al., 2006). Among the 14 members of NALP family, NALP1 and NALP3 are
the most significant ones. These NALP proteins contribute to the assembly
of a structure called inflammasome, which is crucial for the processing and
activation of caspase-1 (Martinon and Tschopp, 2005). NALPs regulate the
production and release of IL-1β , one of the most important pro-inflammatory
cytokines, by recruiting the adaptor protein ASC (Agostini et al., 2004; Marti-
non et al., 2002). It has been shown that bacterial and viral RNA induce IL-1β
and IL-18 secretion in murine macrophages in a NALP3-dependent manner
(Boyden and Dietrich, 2006; Kanneganti et al., 2006; Gasse et al., 2007). Re-
cently, Maitra and colleagues demonstrated that alkane particles are able of
activating NALP3 after being up-taken by the cells (Maitra et al. 2009).
Cytoplasmic RLH receptors are involved in TLR-independent recognition
of dsRNA, which results in activation of IRFs and NF-κB transcription factors
(Yoneyama et al., 2004). RIG-I receptor recognizes the 5′-triphosphate part
of RNA with fine discrimination between virus and self-RNA (Hornung et al.,
2006). Self-RNA will not be detected by these receptors due to the fact that
during cellular RNA synthesis, the 5′-ends are either modified by adding 7-
methylguanosine caps or removed before entering the cytoplasm (Yoneyama
and Onomoto, 2008).
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1.6 Dendritic Cells
Dendritic cells are considered to be the most efficient antigen presenting cells
(APCs) of the immune system. DCs are master regulators in inducing, sus-
taining and regulating immune responses. These cells have a life span of days
up to few weeks and are morphologically characterized by lamellipodia-like,
flat membrane extensions (Banchereau et al., 2000; Steinman et al., 2003;
Shortman and Naik, 2007).
At steady-state, immature DCs constantly sample their environment while
circulating in the body and upon capturing antigen become activated and
migrate to lymphoid organs where they present antigens to the naïve T cells
(Schuurhuis et al., 2006). Since DCs, in addition to TLRs, express a large
array of receptors including Fcγ and C-type lectin receptors on their plasma
membrane, they are able to sense and discriminate a broad range of self and
non-self molecules (Takeuchi and Akira, 2007; Ishii et al., 2008). Depending
on the nature of the pathogen, many of the above-mentioned receptors may
be involved in the detection process. Phagocytosis and receptor-mediated
endocytosis facilitate the engulfment of pathogens by DCs (Sallusto et al.,
1995; Jiang et al., 1995).
DCs not only possess the ability to prime naïve T cells and initiate an
immune response but also to inhibit adverse response against self-proteins by
modulating immunological tolerance (Tarbell et al., 2006). With the signif-
icant capacity of coordinating immune response, DCs are considered one of
the key candidates for prevention and therapy of different medical conditions,
such as infectious diseases, allergy, autoimmunity, cancer and transplantation
(Steinman, 2007).
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1.6.1 DC origin and subsets
DCs are originated from both myeloid and lymphoid precursors (Ardavin et
al., 1993). Although both lymphoid- and myeloid-derived DCs share common
features, different DC subtypes exhibit distinct characteristics, locations in
the body and functions (Hacker et al., 2003; Zenke and Hieronymus, 2006; Ju
et al., 2008; Vremec and Shortman, 1997). The differentiation pathways of
different DC subtypes are illustrated in Figure 1.4.
Classical or conventional dendritic cells are originated from common DC
progenitors (CDPs) in bone marrow tissue. This subpopulation of DCs has
the high potency of both antigen uptake and cytokine secretion (Geissmann
et al., 2010). Conventional DCs display a high level of CD11c and MHC II
(major histocompatibility complex II) and co-stimulatory molecules, such as
CD40, CD80 and CD86 (Banchereau et al., 2000).
pDCs are also differentiated from CDPs and are well characterized by TLR-
mediated type I interferon production in response to viral infections (Diebold
et al., 2004). They express pDC specific markers PDCA-1 and Siglec-H and
are rather poor phagocytes. These cells are able to secrete high amount of
IFNα, IL-6 and IL-10 (Romani et al., 2010; Merad and Manz, 2009).
Langerhans cells (LCs) are the cutaneous contingents of DCs and seed the
skin during embryonal life (Chorro et al., 2009). They reside in the epider-
mis and are responsible for capturing pathogens entering the skin. Due to
their long dendritic extensions, they form a network, which covers the whole
epidermis (Geissmann et al., 2010; Banchereau et al., 2000). LCs are morpho-
logically different from other DC subtypes and specifically express langerin
and Fcε receptors, but not Fcγ receptors (Maurer et al., 1998). Another
LCs exclusive feature is the presence of Birbeck granules in their cytoplasm
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that belong to the endosomal recycling network of these cells (Mc Dermott
et al., 2002). Upon inflammation, Ly-6C+ monocytes can develop into LCs
(Geissmann et al., 2010), however, how they relate to conventional steady-
state LCs, is currently under investigations (T. Hieronymus, J.-H. Beak, J.
Oberblöbaum, K. Sere and M. Zenke, unpublished).
Figure 1.4: Developmental pathways of DC subsets from hematopoietic stem cells. Com-
mon DC progenitors (CDP) give rise to pDCs and cDCs (left), whereas langerhans cells
differentiate from MDP derived Ly-6C+ monocytes (right; Geissmann et al., 2010).
1.6.2 DC maturation and T cell priming
As mentioned earlier, immature DCs constantly patrol the body and sample
pathogenic material in both soluble and particulate forms. Subsequently, they
become activated and migrate to the lymph nodes to prime naïve T-cells. The
transition from antigen capturing to antigen-presenting state is associated
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with dramatic morphological changes and alteration of the genetic profile of
DCs (Gatti and Pierre, 2003).
At their immature state, DCs are efficient phagocytes and express low lev-
els of MHC II and co-stimulatory molecules CD40, CD80, CD83 and CD86
on their surface. They also lack the DC-specific maturation marker DC-
LAMP (lysosome-associated membrane protein). Upon uptaking pathogens,
DCs down-regulate molecules involved in adhesion, phago/endocytosis, re-
structure their cytoskeleton and display higher cellular motility. In this con-
text, they up-regulate expression of MHC II and co-stimulatory molecules as
well as DC-LAMP and CCR7 (Vremec and Shortman, 1997; Wu et al., 1996).
These antigen-loaded DCs then migrate to the nearest draining lymph nodes
to initiate the immune response (Bancherreau et al., 2000).
In order to prime naïve T-cells, DCs need to convert captured pathogen to
short peptide fragments. These small portions will be loaded onto MHC I/II
molecules and serve as ligands for T-cell receptors. In the classical pathway,
self and viral peptides are loaded onto MHC I and activate CD8+ T cells,
whereas non-self peptides via MHC II molecule are presented to CD4+ T cells
(Gatti and Pierre, 2003; Hubbell et al., 2009).
Mature DCs are able to polarize naïve T cells to differentiate to helper
T cell 1 (TH1) or TH2 cells. If the naïve T cells are primed to TH1 cells,
the immune response will be associated with the secretion of inflammatory
cytokines, mainly IFNγ, IL-2. In contrast, activation of TH2 pathway results
in IL-4, IL-5 and IL-10 secretion and elicits a tolerogenic response (Figure 1.5;
Shortman and Liu, 2002).
33
Figure 1.5: Activation state of DCs dictates the nature of T-cell responses. Quiescent
DCs maintain the tolerance state in the body whereas activated DCs direct the naïve T
cells toward TH1 or TH2 immune response (Shortman and Liu, 2002).
1.7 Aim of this study
For a long period of time, TLRs were known for their crucial role in microbial
and viral recognition. However, recent reports indicate that these receptors
are also involved in inflammatory reactions against a wide range of natural
and synthetic molecules (Table 1.1).
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Recently, TLRs have been implicated in the immune response against hy-
droxyapatite (HA) and oxidized alkane polymers (Grandjean-Laquerriere et
al., 2007; Maitra et al., 2008).
Given the crucial function of DCs in the regulation of the immune system,
it is not surprising that some biomaterials induce the up-regulation of surface
markers and the secretion of pro-inflammatory cytokines in murine and human
DCs (Babensee and Paranjpe, 2005; Babensee, 2008).
However, current knowledge on the role of DCs in synchronizing immune
response to foreign material is limited to few studies (Inder et al., 2000). This
might be due to the late discovery of DCs compared to other immune cells
and still incomplete understanding of DC biology.
DC subtypes not only have distinct morphologies, locations and functions
but also express different sets of TLRs (Hochrien and O’Keeffe, 2008). In
mice all cDCs express TLR2, TLR4, TLR 6 and TLR9 (Naik et al., 2005;
Applequist et al., 2002), whereas pDCs lack TLR2, 3, 4, 5 and 8, thus are not
responsive to bacterial products (Bennett et al., 2005). Differential expression
of TLRs by DC subtypes has captured the attention of researchers to develop
new DC-based immunotherapeutic strategies (Schreibelt et al., 2010; Benko
et al., 2008).
As elaborated above, biomedical polymers, despite being non-cytotoxic,
have a profound influence on immune cells. Thus, regardless of the clinical
application at hand, there is a major need to understand how biomedical
polymers affect their function. With this premise in mind, in this study I
have analyzed the influence of an array of chemically and physically diverse
biomaterials on DC function using several murine knockout systems.
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Chapter 2
Materials and Methods
2.1 Preparation of biomaterials
Synthetic biodegradable and non-biodegradable polymers used in this work
were either purchased in medical grade quality as certified by the compa-
nies and used as provided or purified further in the laboratory of DWI e. V
and Institute of Textile and Macromolecular Chemistry at RWTH University,
Aachen. The manufacturing process of each biomaterial is described in the
following sections. For more information on chemical structures and medical
applications of the biomaterials see Figures 5.1 and 5.2 in the appendix.
2.1.1 Alginate
Sodium alginate (Sigma-Aldrich, Germany; cat. no. 71238, MW: 403 kDa)
is a heterogeneous mixture of alginates from different sources of brown algae.
It was purified under sterile conditions according to Zimmermann and Lein-
felder (Zimmermann et al., 1992; Leinfelder et al., 2003 ). An additional pu-
rification was done by preparative chromatography [PrimesepC column (Sielc
Technologies), mobile phase 20 mM Na2HPO4 pH 6.5; flow rate 0.25 mL/min].
The eluted alginate fraction was treated with standard antibiotics (100 U/mL
Penicillin, 100 µg/mL Streptomycin), dialyzed overnight and lyophilized. At
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this stage, a white sodium alginate powder was obtained. Fluorescence spec-
troscopy (LS50, Perkin Elmer, Germany, λexcitation 366 nm, λemission 300-500
nm) was used to determine polyphenolic impurities in sodium alginate be-
fore and after purification. Analysis of spectra was done using Perkin Elmer
software. Protein content was measured by automatic amino acid analysis ac-
cording to Spackman (Spackman et al., 1958). Alginate films were prepared
by adding 1% alginate (1 gram alginate in 100 mL of double distilled water)
to 0.5 mL of 0.01 M CaCl2 (in double distilled water) and stirred for 24 h to
get a clear solution. The solution was filtered through a 0.2 µm filter cap and
spun (3000 rpm, 40 seconds) onto clean ∅12 mm cover slips.
2.1.2 Poly(ε-caprolactone)
Poly(ε-caprolactone) (PCL, MW: 80,000 g/mol) was purchased from Sigma-
Aldrich (Germany). Film preparation was done using a homemade thermo-
mechanical press. PCL (3 g) was placed on Teflon-covered metal plates, the
temperature of the plates was raised to 85◦C and maintained for 5 min. A
load of 1 tonne was applied for 1 min at the same temperature. The foil was
removed after cooling the metal plates to room temperature. The foil was
washed several times with isopropanol (Fluka, Germany), Tween 80 (aqueous
0.02 mM, Roth, Germany) and urea (8 M, Roth, Germany) solutions before
rinsing with deionized water. Afterwards PCL samples were dried in a vacuum
oven for 24 h at 40◦C. Samples (∅ 12 mm or 6 cm) were cut out with a hole
puncher, packaged in TCPS wells and stored at 4◦C in the dark.
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2.1.3 Resomers R©
Poly(L-lactic acid) (L209S, 2.6-3.2 dL/g), poly(D,L-lactic acid) (R203S, 0.25-
0.35 dL/g), poly(D,L-lactic acid-co-glycolic acid) (RG503, lactic acid-glycolic
acid ratio 50:50, 0.32-0.44 dL/g), poly(L-lactic acid-co-D,L-lactic acid) (LR704,
L-lactic acid-D,L-lactic acid ratio 70:30, 2.0-2.8 dL/g), and poly(L-lactic acid-
co-trimethylene carbonate) (LT706, lactic acid to trimethylene carbonate ra-
tio 70:30, 1.2-1.6 dL/g) were purchased from Boehringer Ingelheim Pharma
(Germany). L209S, LR704, RG503, and LT706 foils were prepared by melt-
pressing technique as for PCL (see above). For the preparation of the R203S
foils by solvent evaporation technique, polymer solution in chloroform (10
g/60 mL) was prepared and transferred into a PTFE mould. Films were pre-
pared under controlled evaporation conditions for 24 h. All Resomer foils were
cleaned, packaged, and stored as described for PCL. A hexane/isopropanol
mixture (79:21, v/v) was used to extract the foils overnight in Soxhlet un-
der nitrogen gas atmosphere. Afterwards samples were washed in Tween 80
(aqueous 0.02 mM, Roth, Germany) and urea (8 M, Roth, Germany) as for
PCL. After washing with deionized water, samples were dried in a vacuum
oven for 24 h at 40◦C. Samples were packaged in TCPS wells, stored at 4◦C
in the dark.
2.1.4 Texin R© 950
Aromatic polyether-based thermoplastic polyurethane (PEU) (Texin R© 950)
was purchased from Bayer Material Science AG (Germany). Three grams of
granules per foil were pre-heated at 120◦C for 1 h. Afterwards, the heated
granules were placed at the centre of pre-heated metal plates coated with
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aluminum foils. The temperature of the press was then raised to 200◦C for 5
min and a load of 5 tonnes was applied for 10 s. Texin R© 950 foils were removed
after cooling down the metal plates to room temperature. The thickness
of the foils was approximately 230 µm. Extraction of Texin R© 950 samples
with hexane/ethanol mixture (79:21; v/v) was carried out in a Soxhlet under
nitrogen gas atmosphere, as above. Texin 950 samples were washed in Tween
80 (aqueous 0.02 mM, Roth, Germany) and urea (8 M, Roth, Germany) and
several times with deionized water. The samples were dried for 2 h at 80◦C
and for 2 days in a desiccator under vacuum.
2.1.5 Poly(dimethyl siloxane)
Poly(dimethyl siloxane) (PDMS) foils were prepared by film casting method
from Sylgards 184 (Dow Corning, USA). Base and curing agent were mixed
10:1 (w/w; bubble formation was prevented by evaporation), the mixture was
cast on a cleaned glass plate and spread with a scraper to obtain a thickness
of 1 mm and incubated for 1 h at 150◦C. Samples were removed and cleaned
twice by sonication (10 min each) in ethanol. After drying in a nitrogen
stream, samples were incubated in 8 M urea solution and afterwards in 0.02
mM Tween 80. After rinsing vigorously with deionized water samples were
dried in a desiccator under vacuum for two days.
2.1.6 Poly(ethylene terephthalate), poly(tetrafluoro ethy-
lene), and poly(vinylidene fluoride)
Foils of poly(ethylene terephthalate) (PET), poly(tetrafluoro ethylene) (PTFE),
and poly(vinylidene fluoride) (PVDF) were purchased from Goodfellow GmbH
(Germany). The thicknesses of PET, PTFE and PVDF foils were 125, 300
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and 50 µm, respectively. The polymer foils were extracted for 2 h in a Soxhlet
apparatus using a hexane/ethanol mixture (79:21 v/v) and then dried at 80◦C
for 1 h. Afterwards the samples were kept under vacuum at room tempera-
ture for 24 h. Finally, samples were washed in 8 M urea and 0.02 mM Tween
80 solution for 1 h at 25◦C. After rinsing vigorously with deionized water,
samples were dried in a desiccator under vacuum for 20 h.
2.2 Biomaterial sterilization
Biomaterial disks were sterilized using a standard UV lamp, installed in lam-
inar flow hood. Each piece of the biomaterial was placed in a sterile tissue
culture dish and both sides of biomaterial were exposed to UV light for 30 min.
Biomaterials were always handled carefully, using sterile gloves and forceps.
2.3 Physico-chemical analysis of biomaterials
Comprehensive chemical and physical analyses including gravimetry, UV/VIS
and FTIR spectrophotometry, pH metry and stereomicroscopy of the biomate-
rials were carried out under the supervision of Prof. Vasif Hasirci, Department
of Biological Science, Biology Research Unit at Ankara University, Turkey.
Biomaterial disks (15 mm in diameter) were initially dried at 50◦C for 1.5 h
under vacuum. Afterwards, they were placed in 12-well polystyrene tissue cul-
ture plates and sterilized (30 min for each side) using a standard laminar flow
cabinet UV lamp. After adding sterile PBS (4 mL, 10 mM, pH 7.2) to each
well, biomaterials were incubated at 37◦C, 5% CO2 for 3 days. During this
period, the lids of the tissue culture plates were sealed with parafilm to avoid
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any evaporation. PBS was exchanged every 24 h. For the gravimetric anal-
ysis at the end of each incubation day, biomaterial disks were removed from
the wells, dried at 50◦C for 1.5 h under vacuum and weighed. The UV/VIS
spectra of supernatants collected from the wells were obtained at the end of
each incubation day using a spectrometer (Multiskan Spectrum UV/VIS spec-
trophotometer, Thermo Fisher, USA) in the 200-650 nm range. Stock PBS
was used as reference. Measurements of pH changes were done following the
incubation of polymer disks in ultrapure water (to prevent any interference
from salts in the PBS) using a standard pH meter (Eutec Cyberscan pH510,
Thermo Fisher, USA). Stereomicroscopic images of samples treated exactly
the same way but incubated in PBS instead of ultrapure water to mimic the
biological conditions were taken before and 3 days after the incubation of
the biomaterial disks for documenting signs of gross morphological changes
(Stereomicroscope SMZ-1500, Nikon Co., Japan).
2.4 Determination of endotoxin concentration
in biomaterials
The amount of endotoxin released by, or adsorbed on, biomaterial films was de-
termined as described below. For released endotoxin, biomaterials were incu-
bated in endotoxin-free distilled water at 37◦C for 24 h. Absorbed level of en-
dotoxin was determined after incubation of the biomaterials in endotoxin-free
distilled water at 37◦C, for 60 min with constant shaking. Afterwards, samples
(water) were collected under sterile condition and transferred to endotoxin-free
tubes. Endotoxin levels were quantified using the LAL kinetic chromogenic
assay at the European LAL Testing Service (Lonza, Verviers, Belgium).
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2.5 Mice
C57BL/6 WT and MyD88−/− mice were bred and maintained at the animal
facility of the Aachen University Hospital. Single TLR knockout mice were
bred and maintained at the animal facility of the laboratory of Host Defense,
immunology Frontier Research Center (iFREC) and Wolrd Premier Immunol-
ogy Institute (WPI), Osaka, Japan. Handling of mice was done according to
institutional guidelines.
2.6 Cell culture
2.6.1 Growth media
The basal growth medium for T cells and DCs was RPMI 1640 (Gibco) sup-
plemented with 10% heat-inactivated FCS (PAA gold), 2 mM L-glutamine
(Gibco), 100 µg/mL streptomycin (Gibco), 100 U/mL penicillin (Gibco) and
50 µM 2-mercaptoethanol (Sigma). Cells were grown at 37◦C, 5% CO2 (HER-
Acell 240, Thermo Scientific).
2.6.2 Generation of bone marrow-derived DCs
Tibia and femur from C57BL/6 WT or MyD88−/− mice (8-12 week old) were
transferred to 5 mL of DC medium and bone-marrow-derived DCs (BM-DCs)
were generated as already described (Hieronymus et al., 2005).
Briefly, under sterile conditions, the bone marrow was flashed out using a 1
mL syringe equipped with 23G needle. Isolated bone marrow progenitor cells
(BMPCs) cells were then re-suspended in DC medium by gentle pipetting and
their concentration adjusted to 2 x 106 cells/mL in DC medium supplemented
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with 30U/mLmuSCF, 5 ng/mL hyperIL-6 (kindly provided by Dr. Rose-John,
Kiel), 25 ng/mL Flt-3L (PeproTech), 40 ng/mL huIGF-1 long range (Sigma),
25U/mL muGM-CSF (Pharmed) and 1 µM dexamethasone (Sigma).
After 3 days of culture, dead cells, erythrocytes and debris were removed by
density gradient centrifugation using Lymphocyte separation medium Ficoll-
Hypaque (LSM 1077; PAA). To this end, 14 mL of LSM were gently overlaid
onto 20 mL of cell suspension in a 50 mL conical tube and centrifuged for 15
min at 2.000 rpm at RT. After collecting BMPCs from the interphase, cells
were washed with 20 mL of basal DC medium and their density adjusted to
2 x 106 cells/mL. During the expansion of BMPCs, the medium was renewed
every second day taking care to keep the cell density at 2 x 106 cells/mL.
At day 7 of culture, the differentiation of BMPCs into DCs was initiated (2
x 106 cells/mL) in DC medium containing only 250U/mL muGM-CSF. Also
during the differentiation phase, the medium was renewed every second day.
Seven to ten days after initiating the differentiation process, a homogenous
population of immature conventional CD11c+ CD11b+ CD8α− dendritic cells
was obtained.
Alternatively, DCs were generated from BMPCs according to Lutz et al.,
(1999). In this case, BMPCs (2 x 106 cells/10 cm dish) were cultured in RPMI
1640 medium supplemented with 10% FCS, 2 mM L-glutamine, 100 mg/mL
streptomycin, 100 U/mL penicillin (all from Invitrogen Life Technologies), 50
µM 2-mercaptoethanol and 200 U/mL recombinant mouse GM-CSF. After
3 days, 10 mL DC medium containing 20 ng/mL GM-CSF was added to
each dish. At day 6 and 8, half of the cell suspension was centrifuged, re-
suspended in 10 mL of fresh medium containing 20 ng/mL GM-CSF and
returned to the original dish. DCs generated according to the above two
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methods are essentially functional equivalent. Regardless of the protocol used
for DC generation, the maturation of these cells was obtained by adding 2
µg/mL LPS for 24 or 48 h.
2.7 Cytotoxicity Test
Immature DCs (3 x 106) were seeded on ∅ 15 mm biomaterials disks in 12-
well plates. Since biomaterials disks floated in the medium, a silicon ring was
applied on each disk to keep them at the bottom of the well. Silicon rings
in empty (no biomaterials) wells served as negative controls. Following in-
cubation of iDCs on the biomaterials for 24 h at 37◦C, 5% CO2, cells were
gently collected, stained with 1 mg/mL Propidium Iodide (PI Sigma-Aldrich,
Germany) for 2 min at room temperature in the dark and immediately an-
alyzed by flow cytometry (FACSCalibure, Becton Dickinson). PI is usually
excluded from live cells, whereas dead cells stain positive for this dye. The
cytotoxic effect of the biomaterials was expressed as the percentage of dead
cells (PI-positive) in the DC population.
2.8 Gene expression analysis
2.8.1 RNA isolation
Immature DCs (1.2-1.6 x 106) were plated on ∅ 60 mm biomaterial disks or
culture dishes. Following incubation at 37◦C, 5% CO2 for 24 h, cells were
gently collected and washed twice with cold PBS. After the last centrifuga-
tion step, cell pellets were flash frozen in liquid nitrogen and stored at -80◦C.
RNA was isolated using the Tripure Isolation kit (Roche) according to man-
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ufacturer’s instructions.
Briefly, cell pellets were thawed on ice and 1 mL of Tripure isolation reagent
was added per 5-10 x 106 cell. Pellets were lysed and homogenized by repet-
itive pipetting and then incubated for 5 min at RT. Afterwards, 0.2 mL of
chloroform was added to the samples. Tubes were capped, shaken vigorously
for 15 sec and further incubated for 10 min at RT. Samples were then cen-
trifuged at 12.000 x g for 15 min at 4◦C to separate the solution into 3 phases:
RNA, DNA and protein. The upper aqueous phase was carefully collected
and transferred to fresh 1.5 mL RNAse, DNAase free tubes. Next, 0.5 mL of
100% isopropanol was added, mixed thoroughly by inverting the tubes sev-
eral times and incubated for 10 min at RT. Samples were again centrifuged
(12.000 x g for 10 min at 4◦C) and the supernatants discarded. After adding
1 mL of 75% ethanol, samples were vortexed and centrifuged at 7.500 x g for 5
min at 4◦C. The supernatants were discarded and the remaining ethanol was
removed by air-drying. Afterwards, RNA pellets were re-suspended in an ap-
propriate amount of RNAase-free water and dissolved by incubating at 58◦C
for 15 min. RNA samples were kept on ice and the RNA concentration was
measured using a NanoDrop device (ND-1000 NanoDrop technologies. USA).
Purified RNAs were stored at -80◦C.
2.8.2 cDNA preparation
For cDNA preparation, 250 ng of Random hexamer Primer (Fermentas) were
added to 1 µg of RNA and the reaction volume was brought to 10 µL by adding
H2O. The mixture was heated at 70◦C for 5 min and then cooled down on ice.
Afterwards, M-MuLVT buffer (4 µL, 5-fold concentrated, Fermentas), 0.5 µL
of Ribolock Ribonuclease Inhibitor (40 µM/µL Fermentas), 2 µL dNTPs (10
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mM, Fermentas) and 19 µL H2O were added. The mixture was heated for 5
min at 25◦C and then, 1 µL of RevertAid M-MuLV (200 U/µL, Fermentas)
was added. Following incubation at 25◦C (10 min) and 42◦C (60 min), the
reaction was heat inactivated at 70◦C for 20 min. Afterwards, tubes were
cooled down at 4◦C and cDNAs were stored at -20◦C.
Table 2.1: Steps of cDNA preparation.
Substance Amount Cycle program
Random hexamer primer (100 µM) 0.5 µL 5 min, 70◦C-chill on ice
RNA 1 µg
H2O up to 10 µL
5x M-MuLVT buffer 4 µL 5 min, 25◦C
Ribolock Ribonuclease Inhibitor (40 U) 4 µL
dNTPs (10 mM) 0.5 µL
H2O up to 19 µL
RevertAid M-MuLV (200 U/µL) 1 µL 10 min 25◦C, 60 min,
42◦C, 20 min, 70◦C
2.8.3 Real Time Polymerase Chain Reaction (RT-PCR)
cDNA (50 ng diluted with water to 5 µL) and forward and reverse primers (1
µg/each in 10 µL) were mixed with 15 µL SYBR R© Green PCR master mix.
Then, the plate was covered using adhesive seal (Applied Biosystems) and
centrifuged at 1400 rpm for 4 min at 4◦C. Afterwards, the plate was placed
in a PCR machine and run under corresponding program. PCRs were done
using SYBR R© Green PCR master mix detection dye and 7300 Real Time
PCR machine (both from Applied Biosystems). Data were analyzed using
Sequence Detection System (SDS) software v1.4.0.
The expression level of each cytokine in control untreated cells was nor-
malized to 1. For primer sequence detail, annealing temperature and PCR
48 Chapter 2. Materials and Methods
product size see Figure 5.3 in the appendix.
Table 2.2: Steps of RT-PCR program
Step Temperature/time Cycles
Initial activation 95◦C/10 min 1
Denaturation 95◦C/15 sec 40
Anneal/extension 60◦C/1 min 40
2.9 Fluorescence-Activated Cell Sorting (FACS)
Immature DCs (3 x 106) were seeded on ∅ 15 mm biomaterial disks inserted
in 24-well plate at 37◦C, 5% CO2 for 24 h. iDCs seeded on empty well served
as controls. Afterwards, loosely adherent cells were gently removed from bio-
material surface, collected and washed twice with PBS. Approximately 7 x
105 -106 cells were re-suspended in 50 µl FACS buffer (1% BSA in PBS) and
incubated with the selected primary antibodies for 30 min at 4◦C (see Table
2.3). Following incubation, cells were washed twice with 500 µL of FACS
buffer and re-suspended in 50 µL FACS buffer. Cells were then incubated
with secondary or isotype control antibodies for 25 min at 4◦C. After wash-
ing again twice with 500 µL of FACS buffer, cells were re-suspended in 200
µL FACS buffer and kept on ice. The expression of DC surface proteins was
measured by flow cytometry using a FACSCalibur.
For multicolor analysis, the instrument was calibrated using anti-mouse
Ig,κ/negative control compensation particles (Beckton Dickinson). The com-
pensation was done either manually or using automatic instrument settings.
Data analysis was done using CellQuest v3.3 (BD Biosciences).
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Table 2.3: Antibodies used to detect DC surface markers.
Surface marker Antibody description Source
CD11b FITC-conjugated rat anti-mouse CD11b
clone M1/70.15
Caltag
CD11c PE-conjugated hamster anti-mouse CD11c
clone N418
Caltag
CD24 PE-conjugated rat anti-mouse CD24 mAb
M1/69
Pharmingen
CD40 Biotin-conjugated rat anti-mouse CD40
clone 3/23
Caltag
CD80 Biotin-conjugated clone 16-10A1 Pharmingen
CD86 Rat anti-mouse CD86 clone RMMP-2 Serotec
MHC II FITC-conjugated rat anti-mouse MHC II
I-A/I-E mAb clone 2G9
Pharmingen
PE isotype control Hamster IgG isotype (for CD11c and CD24
labelings)
Caltag
APC isotype control Streptavidin APC conjugate (for CD40
and CD80 labelings)
Caltag
PE isotype control Goat F(ab’)2 anti-rat IgG Caltag
2.10 T cell proliferation
CD4+ naïve T cells were isolated from spleens of 6-14 weeks old OT-II trans-
genic mice using immunomagnetic bead selection (CD4+/L3T4 MACS beads,
Miltenyi Biotec, Germany) according to the manufacturer’s protocol. Iso-
lated CD4+ T cells were re-suspended in T-cell medium (RPMI 1640 medium
supplemented with 10% FCS, 2 mM L-glutamine, 50 mM 2-mercaptoethanol,
100 mg/mL streptomycin, 100 U/mL penicillin). For the proliferation assay,
CD4+ T cells were stained with 5 mM CFSE (carboxy fluorescein succinimidyl
ester, Sigma Aldrich, Germany) for 10 min at 37◦C in the dark. At the end
of the incubation, an equal volume of T-cell medium was added to quench
unbound CFSE. Afterwards, cells were washed twice with the same medium
and re-suspended at the desired cell density.
To stimulate their proliferation, CD4+ T cells (1 x 105/well) were incu-
50 Chapter 2. Materials and Methods
bated with DCs (LPS-treated as positive control or biomaterial-treated; 1 x
103/well), which were previously loaded with 0.1 µM OVAII peptides, in a
96-well dish (round bottom, Corning, USA) at 37◦C, 5% CO2. On day 4, T
cells were gently collected and stained with APC-labeled anti-CD4 antibodies
(Caltag, USA). T-cell proliferation was determined by analyzing the progres-
sive twofold dilutions of CFSE that accompanied mitotic cell divisions of the
T-cell population.
2.11 Cytokine measurements
Immature DCs (3 x 106) were seeded on ∅ 15 mm biomaterials disks or in
empty wells for 24 h. Afterward, medium was collected and centrifuged at
1400 rpm for 4 min at RT. The supernatant was carefully collected and stored
at -80◦C. Levels of inflammatory cytokines IL-1β, IL-6, IL-10, IL-12, TNFα
and RANTES were measured using Bio-Plex multi cytokine assay (Bio-Rad,
USA). Briefly, one tube of lyophilized cytokine standard was reconstituted by
adding 500 µL of DC medium and serial dilutions of this standard (concentra-
tion: 32.000 pg/mL) down to 1.95 pg/mL were made according to the assay’s
instruction manual.
Next, a 96-well filter plate was equilibrated with 100 µL of Bio-Plex assay
buffer (then discarded) before adding 50 µL of multiplex bead working solution
and 50 µL of diluted standard or sample to each well. The filter plate was
incubated on a shaker at 300 rpm for 30 min at RT. After washing with Bio-
Plex washing buffer, 25 µL of detection antibody were added to each well and
the filter plate was incubated as described above. Following this incubation,
the plate was washed 3 times with 100 µL Bio-Plex wash buffer before adding
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50 µL of 1x streptavidin-PE to each well and incubating as above. Finally,
the plate was washed 3 times and the beads in each well were re-suspended
with 125 µL of Bio-Plex assay buffer. Following another incubation, the plate
was immediately read using a Luminex 100 Bio-Plex plate reader.
2.12 Immunofluorescence microscopy
Microscopy was done as described in (Pust et al., 2005). Briefly, 24 h after
seeding on biomaterial sheets or poly(L-Lysine)-coated coverslips, DCs were
fixed with 4% paraformaldehyde in cytoskeleton buffer (10 mM PIPES, 150
mM NaCl, 5 mM EGTA, 5 mM glucose, 5 mM MgCl2, pH 7.0) for 30 min at
RT and then extracted with 0.1% Triton X-100 in cytoskeleton buffer for 1
min at RT.
The actin cytoskeleton was labeled with Alexa 594-conjugated phalloidin
(Molecular Probes, Eugene, USA) and nucleus dyed using DAPI staining.
Biomaterial sheets were mounted between a glass-bottomed dish and a glass
cover slip using Prolong (Molecular Probes). Images were acquired by epi-
fluorescence using an Axiovert 200 microscope (Carl Zeiss) equipped with a
Plan-Apochromat 100x/1.40 NA oil immersion objective in combination with
1.6x optovar optics. Images were recorded with a cooled, back-illuminated
charge-coupled device camera (Cascade 512B; Princeton Instruments, Tren-
ton, NJ) driven by IPLab Spectrum software (Scanalytics, Fairfax, USA).
Digital handling of the images was done using IPLab Spectrum and Adobe
Photoshop 8.0 (Adobe Systems, Mountain View, USA). In most of cases, a
mild sharpening filter was applied to enhance the clarity of actin-rich cy-
toskeletal structures.
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2.13 Quantification of podosomes in DCs
To assess the influence of biomaterials on podosome assembly, the number of
podosomes in 250 randomly selected DCs (from 3 independent experiments)
were counted. DCs seeded on glass cover slips served as control. Change
in podosome formation was calculated by determining the variation in the
number of DCs with podosomes (expressed as percent relative to control cells).
2.14 Statistical analysis
All graphs and statistical analyses were done using Prism 5 (GraphPad soft-
ware, Inc., USA). Statistical differences were analyzed using the two-tailed
ManneWhitney nonparametric U test. The null hypothesis (the two groups
have the same median values, i.e. they are not different) was rejected when p
> 0.05.
Chapter 3
Results
3.1 Impact of biomaterials on DC viability
The potential cytotoxic effect of biomaterials on DCs was analyzed by PI
staining. PI binds to double stranded nucleic acids and acrosses the mem-
brane of dead cells, but not live cells. Hence, it is possible to quantify the
magnitude of biomaterial toxicity by measuring the percentage of PI-positive
cells (Suzuki et al., 1997).
Figure 3.1: Cytotoxic effect of non-degradable (A) and degradable (B) biomaterials on
immature and mature dendritic cells. Note the higher cytotoxic effect of PEA C. The cell
death rate of untreated control DCs was normalized to 1.
54 Chapter 3. Results
As shown in Figure 3.1A, non-degradable biomaterials did not have any
measurable cytotoxic effect on the viability of both immature and mature
DCs. Among the degradable biomaterials, only PEA type C induced high
cell death in these cells (Figure 3.1B) and therefore was left out from further
experiments. Thus, the biomaterials used in this study are not toxic for DCs.
3.2 Effect of biomaterials on the expression of
DC surface markers
DCs are able to activate naïve T cells and induce an immune response only
when they are mature and exhibit antigen-presenting properties.
The mature DC phenotype is characterized by the up-regulation of MHC
II and the co-stimulatory molecules CD40, CD80 and CD86 and also involves
the secretion of inflammatory cytokines. Thus, it was particularly important
to determine whether biomaterials can alter phenotype of the immature DCs.
To this end, the levels of the above maturation marker were analyzed fol-
lowing the incubation of immature DCs with biomaterial sheets. Untreated
DCs typically express moderate levels of MHC II that are increased following
their maturation with LPS (Figure 3.2A-D and Figure 3.3). The exposure of
these cells to alginate was sufficient to increase MHC II expression to levels
comparable to those of mature DCs.
Among the biodegradable materials also LT706 and RG503 have the ca-
pacity to induce the up-regulation of this surface marker, although to a minor
extent (Figure 3.2A, and Figure 3.3). While none of the biomaterials caused
the increase of CD86 to the levels usually observed in mature DCs, alginate,
LT706, PCL, PTFE, Texin and RG503 triggered a significant enhancement of
this activation marker (Figure 3.2B and Figure 3.3).
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A similar trend also applies to CD40 those expression levels are moderately
enhanced by alginate, Texin, LT706 and RG503. For this surface marker a
moderate decrease could be observed in DCs incubate with PDLLA (Figure
3.2D and Figure 3.3).
Finally, the expression of CD80 to levels sometime similar or higher than
those measured in LPS-treated DCs was induced by all tested biomaterials
except PVDF, PDMS, PET, PDLLA, and LR704 (Figure 3.2C and Figure
3.3, for the statistical analysis see Figure 5.4 in the appendix).
Overall, these results indicate that apparently inert biomaterials have the
capability to alter the phenotype of mouse DCs.
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Figure 3.2: Effect of the biomaterials on DC surface markers. iDCs were exposed to
biomaterials for 24h and expression of MHC II, CD86, CD80 and CD40 was analyzed by
flow cytometry. Data represent the percentage of marker-positive cells (6-8 measurements
from at least 3 independent experiments). The line in the middle of the box indicates
the median, the top of the box indicates the 75th quartile, whereas the bottom of the box
indicates the 25th quartile. Whiskers represent the 10th (lower) and 90th (upper) percentile,
respectively. Asterisks indicate biomaterials that induced a statistically significant increase
in the expression of surface markers (p < 0.05).
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Figure 3.3: Representative FACS scans of surface marker expression. iDCs: immature
DCs; mDCs: mature DCs (LPS-stimulated); isotype: isotype control for antibody labeling.
3.3 Cytokine expression in DCs in response to
biomaterials
As already mentioned, the up-regulation of surface markers in DCs is asso-
ciated with the production of pro-inflammatory cytokines. Among different
cytokines secreted by mDCs, IL-1β, IL-6, IL-10, IL-12, RANTES and TNFα
play a crucial role in the regulation of the immune response.
Numerous studies have shown that biomaterials such as PDMS, ePTFE,
alginate, titanium or cobalt-chrome surfaces induce the secretion of these cy-
tokines in human and murine macrophages (Bonfield et al., 1992; Anderson
et al., 1995; Jones et al., 2004; Sethi et al., 2003; Rafai et al., 2004; Li et al.,
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2005; Yang and Jones, 2009). Thus, since biomaterials induce in DCs a ma-
ture phenotype, it is possible that these polymers also influence the generation
and secretion of cytokines in these cells.
According to the amount of mRNA specific for the subunit p40 of IL-12,
one of the main cytokines produced in TH1 response (Koch et al., 1996), only
RG503 induced a robust increase (more than 10-fold) of this cytokine. Also
LT706, alginate, PCL and PTFE significantly enhanced IL-12p40 expression
above the levels observed in untreated cells (Figure 3.4A).
Similarly, IL-10, an anti-inflammatory cytokine (Janeway and Tavers, 1997;
Abbas et al., 1997), was strongly up-regulated by both RG503 and LT706. Al-
ginate, Texin and PCL also elicited IL-10 secretion though to a lesser extent
(Figure 3.4A). In contrast to IL-12 and IL-10, RANTES also known as CCL5
which is a chemokine that plays an important role in recruiting T cells and
other leukocytes to sites of inflammation (Janeway and Tavers, 1997), was not
affected by any of the biomaterials tested (Figure 3.4A).
Of the remaining cytokines, IL-1β, a pro-inflammatory cytokine secreted
by many immune cells that has already been demonstrated to be involved in
the inflammatory response to biomaterials (Schutte et al., 2009; Anderson et
al., 2008; Dalu et al., 2000; Al Saffar and Revell, 1994), was significantly up-
regulated by all biomaterials. In this context, RG503 was the most reactive
followed by PLLA and PTFE (Figure 3.4B).
Given the strong expression of IL-6, a cytokine having both pro- and
anti-inflammatory properties, in RAW264.7 macrophages exposed to alginate
(Iwamoto et al., 2005), it was not a surprise that the expression of this cy-
tokine was augmented also in DCs.
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Figure 3.4: Biomaterial-induced cytokine production in DCs. After 24 h incubation of
iDCs with biomaterials the mRNA levels of IL-1β, IL-6, IL-10, IL-12p40, RANTES and
TNFα was determined by RT-PCR. Cytokine level is expressed as fold change relative to
control (normalized to 1) untreated cells. Insets in A and B show cytokine expression in
DCs treated with 2 mg/mL of LPS for 24 h.
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Precisely, RG503 was the most potent IL-6 inducer followed by LT706 and
PTFE. Importantly, alginate and PLLA, which stimulated the generation of
some of the above cytokines, affected IL-6 expression to a minor extent (Figure
3.4B).
Another janus-faced cytokine, having both pro- and anti-inflammatory
properties (Murray et al., 1997), is the tumor necrosis factor alpha (TNFα).
TNFα expression was robustly up-regulated only in DC exposed to PDLLA,
PTFE and RG503 (Figure 3.4B). RNA isolation from DCs incubated with
LR704 was not possible. This probably was due to the fact that upon expo-
sure to medium this biomaterials release molecules which interfere with RNA
isolation process.
Table 3.1: Overall reaction of DCs to the biomaterials at surface marker and cytokine
level.
CD40 CD80 CD86 MHC II IL-1β IL-6 IL-10 IL-12 TNFα
Alginate - + + + + + + ++ -
LR704 - + + -
LT706 - + + + + ++ +++ +++ +
PCL - + + - + - + + +
PDLLA - - - - + + - - ++
PDMS - - - - + + - + -
PET - + - - + - - - -
PLLA - + + - ++ + - + +
PTFE - + + - ++ ++ - + +
PVDF - + - - + + - - -
RG503 - + + + +++ +++ +++ +++ +
Texin - + + - + - - + -
Taken together with the effect on DC maturation markers, these finding
clearly demonstrate that some biomaterials can alter DC biology inducing in
these cells a mature phenotype (Table 3.1).
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3.4 Influence of biomaterials on the ability of
DCs to prime T cells
One of the most important properties of mature DCs is their ability to induce
the proliferation of naïve T cells.
Since biomaterials induce in DCs a mature phenotype, it is possible that
DCs exposed to biomaterials have also acquired the ability to activate naïve T
cells. To test this hypothesis, the proliferation of naïve OVAII-specific CD4+
T cells incubated with biomaterial-treated DCs can be conveniently assessed
using the intracellular fluorescent dye CFSE by measuring its progressive two-
fold decrease that accompanies mitotic cell divisions of T cells.
As predicted, DCs that were incubated with the biomaterials that mostly
altered their phenotype such as alginate, LT706, and RG503 induced a very
robust T-cell proliferation often comparable (or even higher) to that induced
by LPS-stimulated DCs (Figure 3.5A, C).
Consistent with these observations, mildly reactive (i.e. not causing much
change in DC phenotype) biomaterials such as PDLLA and PDMS had a
minimal impact on the ability of DCs to activate naïve T cells (Figure 3.5A,
B).
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Figure 3.5: Biomaterials Impact on T-cell stimulatory capability of DCs.
(A) Biomaterial exposed immature DCs were loaded with OVAII peptide and then in-
cubated with CFSE-labeled OVAII-specific CD4 naïve T cells. T cell proliferation was
measured by the progressive two-fold dilutions of CFSE . T cells alone, iDCs and mDCs
w/o peptide served as negative controls for T cell proliferation. Data represent at least
two independent experiments. Error bars indicate the standard error of the mean. (B,C)
representative FACS profile of T cell proliferation rate in co-culture T cell with (B) poor
reactive biomaterials and (C) highly reactive biomaterials. The shift of the CFSE signal
from right to the left indicates T cell division.
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3.5 MyD88 signaling pathway in DC response
to biomaterials
Since biomaterial-induced up regulation of activation markers and cytokines
resembles that promoted by the interaction of DCs with bacterial or viral
pathogens (Malissen and Ewbank, 2005; Lopez-Bravo and Ardavin, 2008), it
is reasonable to hypothesize that receptors involved in pathogen recognitions
are also involved in biomaterial-DC interactions.
Among the different types of receptors expressed by DCs, TLRs play a
major role in DC response to microbial products and are, therefore, likely can-
didates for biomaterial recognition or sensing. Since all TLRs (except TLR3)
signal via the adapter protein MyD88 (Ishii et al., 2008), this hypothesis was
initially tested using MyD88−/− DCs.
When compared to wild-type cells, DCs lacking MyD88 were much less
responsive to the incubation with biomaterials. More precisely, none of the
surface markers CD40, CD86 and MHC II were up-regulated to the levels
measured in WT cells (Figure 3.6A).
This behavior is consistent with the fact that MyD88−/− DCs respond less
efficiently to LPS (Figure 3.6B, C, D). The refractory reaction of MyD88−/−
DCs to biomaterials was also confirmed by the almost complete inhibition of
the secretion of pro-inflammatory cytokines (Figure 3.7A, B, D, F).
A notable exception was represented by IL-10 and RANTES. In particular,
the stimulation of the latter induced by alginate was comparable in wild type
and MyD88−/− DCs (Figure 3.7E).
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Figure 3.6: Comparison of surface markers expression in WT and MyD88−/− DCs af-
ter 24h incubation with biomaterials. (A) CD40, CD86 and MHC II expression level in
DCs lacking MyD88 is strongly impaired compared to WT. (B-D) Hypo-responsiveness of
MyD88−/− DCs to LPS stimulation.
Similarly, the synthesis of IL-10 induced by all biomaterials was not af-
fected (Figure 3.7C), suggesting that the biomaterial-stimulated secretion of
these cytokines is regulated by MyD88-independent mechanisms (see Figure
5.5 in the appendix for the statistical analysis). Collectively, these findings
indicate that MyD88/TLR signaling cascades primarily mediates DCs sensing
of, and reaction to, biomaterials.
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Figure 3.7: Comparison of cytokine secretion in MyD88−/− and WT DCs in response
to biomaterials. Except IL-10, production of all cytokines is either completely abolished
(A, B, D and F) or impaired (E) in DCs lacking MyD88−/−. Data represent at least two
independent experiments. Error bars indicate the standard error of the mean.
3.6 Role of pattern recognition receptors in DC-
biomaterial interactions
As previously mentioned, TLRs signal mainly via adaptor molecule MyD88
and each TLR recognizes specific molecular structures. To determine which
TLRs are involved in DC response to biomaterials, DCs lacking single TLRs,
the NLR family danger sensor NALP3 and the adaptor molecule ASC were
used.
When testing the involvement of TLRs in biomaterial-cell interaction,
one of the main concerns is the contamination of biomaterial samples with
pathogenic products (primarily endotoxin/LPS) that would cause a biomaterial-
independent DC activation. To exclude this possibility, biomaterial samples
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were, therefore, tested for endotoxin contamination.
As shown in the Table 3.2, by using two different procedures the highest
measurable level of endotoxin was 0.096 ng/mL. Since these values are well
below the UPS standard for clinical applications (<0.25 EU/mL) and the
minimal amount of LPS (100 ng/mL) usually used to activate DCs, it is clear
that the biomaterial used in this study were essentially endotoxin-free.
For the following analyses, TLR3−/− DCs were not included in the study
since this TLR signals exclusively via MyD88-independent pathways. More-
over, cytokines that were up-regulated more than 2-fold were taken into ac-
count. By this criterion, PDMS was excluded from the following experiments
since the levels of cytokines that it stimulated were always below this thresh-
old.
Table 3.2: Quantification of the amount of endotoxin released by biomaterials
Endotoxin level
Biomaterial Attached Releasedng/µL ng/µL
Alginate 0.096 0.021
LT706 0.0018 <0.0045
PDLLA 0.013 0.0052
PDMS 0.0034 <0.0045
PDMS 0.0034 <0.0045
PET 0.0078 <0.0045
RG503 0.0037 <0.0045
A common theme that emerged using single TLR KO cells was that the
lack of TLR4 inhibited the up-regulation of surface markers and cytokines
induced by most of the biomaterials (Figure 3.8).
More precisely, alginate-induced secretion of all cytokines was inhibited in
TLR4−/− DCs, whereas the generation of IL-10 and IL-12p40 induced by
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LT706 and RG503 was not affected in these KO cells. The deletion of TLR4
seems to be less crucial for the interaction between PDLLA and PET as
suggested by the fact that only IL-1β and TNFα were affected in DCs lacking
this receptor (Figure 3.8B). Remarkably, the secretion of IL-10 and RANTES,
which was unaffected in DC lacking MyD88, was inhibited in TLR4−/− cells
suggesting that MyD88-independent signaling is involved in the biomaterial-
triggered generation of these cytokines.
TLR2 and TLR6 were involved in DC-biomaterials interactions. The dele-
tion the former receptor impaired IL-6 secretion induced by LT706 or RG503
(Figure 3.8C). TLR2−/− DCs also secreted less RANTES in response to RG503
(Figure 3.8C). In the absence of TLR6, the production of IL-6 and RANTES
was also impaired (Figure 3.8C). As expected, the impairment or inhibition
of cytokine secretion was mirrored by the absence of surface markers up reg-
ulation in DCs lacking the above TLRs (Figure 3.8D-F).
Thus, my findings demonstrate that the subversion of DC function by
biomaterials is primarily mediated by TLR4, although TLR2 and TLR6 also
have an influence in the context of specific biomaterial-cytokine combinations.
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Figure 3.8: Involvement of TLR2, 4 and 6 in DC-biomaterial interactions. The protein
expression level of IL-1β, IL-6, IL-10, IL-12p40, RANTES and TNFα induced by the bio-
materials was almost completely abolished in DCs lacking TLR4 (A, B). The lack of TLR2
or TLR6 also caused a significant reduction of IL-6 and RANTES (C). Data represent at
least two independent experiments. Error bars indicate the standard error of the mean. (D-
F) DCs lacking TLR2−/− (D), TLR4−/− (E) and TLR6−/− (F) did not up-regulate CD40
in response to biomaterials. iDCs: immature DCs; mDCs: mature DCs (LPS-stimulated);
isotype: isotype control for antibody labelling.
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3.7 Effect of serum proteins on DC-biomaterial
interactions
Immediately after a medical device is implanted, a layer of host serum proteins
is absorbed onto its surface (Anderson, 2001). Current notion suggest that
the host reaction against the implant is initiated by the interaction of immune
cells with this protein layer rather than with the biomaterial itself.
To determine to which extent serum proteins influence the reaction of
DCs to biomaterials, the expression of maturation markers and cytokines was
evaluated under normal or serum-free conditions.
Figure 3.9: Comparison of surface marker expression of DCs in response to biomaterials
under serum-free and normal conditions. Under serum-free condition higher expression
levels of MHC II and CD86 was observed for few of the biomaterials (A, B). The expression
of CD40 and CD80 was not grossly affected in the serum-free condition (C, D).
In the absence of serum, the response of DCs to LPS was reduced as
indicated by the reduced up-regulation of most of the surface markers and
cytokines (Figure 3.9A-D and Figure 3.10A-D). The expression of surface
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markers induced by biomaterials in serum-free media was not grossly af-
fected, although a trend towards higher levels of MHC II was observed for
LT706, PDLLA and RG503 (Figure 3.9A). Similarly expression of the CD86
was higher for Alginate, LT706, PDMS and RG703 although to a less extent
compared to MHC II (Figure 3.9B).
While the mRNA levels of IL-6 and IL-12p40 were similar for both ex-
perimental conditions (Figure 3.10B, C) the stimulation of IL-1β by LT706,
PDLLA, PDMS and RG503 decreased in the absence of serum (Figure 3.10A).
Similarly the expression of TNFα triggered by all biomaterials except PET
was lower when serum was omitted (Figure 3.10D).
Figure 3.10: Comparison of cytokine secretion of DCs in response to biomaterials under
normal and serum free conditions at mRNA level. Under normal condition DCs were more
responsive to LPS stimulation and produced significantly higher amount of inflammatory
cytokines (A-D). Under both conditions cells produced the same amount of IL-6 and IL-
12p40 (B, C), whereas the expression of IL-1β and TNFα was reduced in the absence of
the serum (A, D).
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3.8 Response of biomaterial-exposed DCs to LPS
stimulation
Given the profound changes caused by the biomaterials on DCs, it was impor-
tant to test whether DCs exposed to biomaterials are still able to sense and
respond to danger signals. The inhibitory effect of certain materials on DC
response to further stimulations has been reported by Beamer et al. (2008).
To address this issue, iDCs were exposed to biomaterials for 24 h, gently
collected and then stimulated with LPS. As shown in Figure 3.11A,B the pre-
incubation of DCs with biomaterials did not impair their ability of these cells
to respond to LPS.
A notable exception was represented by DCs exposed to PDLLA that
were not responsive to LPS treatment (Figure 3.11A-B). Given the fact that
PDLLA was the least effective biomaterial in terms of DC activation, this
observation suggests that this biomaterial can exert an inhibitory effect on
DC function.
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Figure 3.11: Response of biomaterial exposed DCs to the secondary LPS stimulation
at surface marker expression level. DCs incubated with all biomaterials except PDLLA
were capable of sensing and responding to LPS by further up regulating MHC II (A) and
co-stimulatory molecules (A, B).
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3.9 Role of direct and indirect interactions of
degradable biomaterials and DCs
Since some of the biomaterials in this study are degradable, it is reasonable
to hypothesize that DCs not only respond to the biomaterial surface but also
to their degradation products.
To test this hypothesis, immature DCs were seeded in the upper chamber
of 0.4 µm transwell filters, which were inserted in ∅ 12 mm wells containing
alginate, LT706, PDLLA or RG503. Although alginate is not considered a
degradable material, when it is exposed to aqueous solutions it can be hy-
drolyzed or solubilized. Since the hydrolysis or solubilization certainly causes
the release of polymer molecules, alginate was also included in this experiment.
Under control conditions (transwell filters only) the expression of CD40,
CD80, CD86 and MHC II was indistinguishable from that in control DCs (Fig-
ure 3.12B), indicating that the transwell filters did not affect DC phenotype.
As shown in Figure 3.12A, biomaterial-induced surface marker up-regulation
is, in most cases, reduced in the absence of direct biomaterial-DC interac-
tions but not inhibited. These observations were complemented by analysing
physico-chemical changes of alginate, LT706, PDLLA or RG503 after incuba-
tion in aqueous solutions. Under these experimental settings, only the weight
of PDLLA was significantly reduced (Figures 3.13A, 5.6 and 5.7 in the ap-
pendix). Macroscopic examination showed clear signs of deterioration for algi-
nate and, in particular, for PDLLA and RG503 (Figure 3.13B). Despite these
clear signs, it was not possible to identify soluble products using UV/Visible
and FTIR spectroscopy (see appendix 5.9 and 5.10) . Nevertheless, following
incubation in ultrapure water, these polymers caused a robust increase (for
alginate) or decrease (for LT706 and RG503; PDLLA had no significant effect,
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see appendix 5.8) of the pH.
These findings fit the expectations, as it is known that the degradation rate
of polylactide-co-glycolides is higher than that of PLLA or PDLLA mainly
due to their lower crystallinites. Alginate, on the other hand, was prepared
by cross-linking with calcium ions that could be easily reversed in aqueous
media. It is, therefore, reasonable that some leachable substances (absent or
negligible for PDLLA) such as acidic degradation products from LT706 and
RG503 and low molecular weight chains from the alginates have a profound
effect on DCs.
Thus, biomaterials influence DC function by a combination of physical
contact and release of soluble products.
Figure 3.12: Effect of direct contact between cells and biomaterials on their surface marker
expression level. DC were either plated in transwell or directly on the surface of biomaterials
for 24h and the surface marker expression level was analyzed by flow cytometery. (A)
Overall expression of surface markers was reduced in absence of direct contact except for
PDLLA. (B) Comparison of surface molecules expression in iDCs plated in transwell and
iDCs plated on the dish showed no distinguishable differences.
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Figure 3.13: Gravimetric and morphological analysis of alginate, LT706, PDLLA and
RG503. Weigh of the biomaterials changes over 3 days incubation (A). Morphological
alteration is clearly visible in RG503, PDLLA and alginate (B). The significant reduction
in weight of PDLLA corresponds to its profound morphological change.
3.10 Biomaterial-induced podosome formation
Cells re-arrange their cytoskeleton in response to chemokines and environmen-
tal stimuli (Calle et al., 2006). In DCs, the maturation process and the up
regulation of surface markers is accompanied by actin cytoskeleton remodeling
(Ross et al.,2000; Shutt et al., 2000). Moreover, it has been shown that the
activation of TLR4 results in the disassembly of podosomes, actin-rich adhe-
sive structures typical of immune cells, in DCs (van Helden et al., 2006; West
et al., 2004). Therefore, given the involvement of TLRs in DC-biomaterial
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interactions, it is possible that biomaterials affect the ability of DCs to form
podosomes.
To test this idea, iDCs were plated on glass coverslips (control cells) or
biomaterial disks for 24 h. Cells were fixed and labeled with fluorescence
phalloidin. In control DCs, podosomes typically appeared as sparse and dis-
crete structures mostly concentrated towards the periphery of the cells (Figure
3.14A, arrow in inset).
DCs plated on LT706 formed podosomes that were larger but morpholog-
ically less defined than control podosomes. They also formed large clusters
both at the periphery and centre of the cells (Figure 3.14B, arrow in inset).
In contrast to LT706, PDLLA enhanced the formation of podosomes,
which were morphologically indistinguishable from control podosomes, but
distributed throughout the cell’s ventral side (Figure 3.14C, arrow in inset).
DCs plated on PDMS formed bigger podosomes that appeared in clusters
where single podosomes were sometimes connected with thin actin bundles
(Figure 3.14D, arrow and arrowhead in inset). In DCs plated on PET the
podosomes (heterogeneous in size) were exclusively assembled in clusters at
the cell periphery (Figure 3.14E, arrow in inset).
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Figure 3.14: Biomaterials alter podosome formation in DCs. Immature DCs were plated
on glass cover slips (control) or on thin biomaterial films, fixed and stained with fluorescent
phalloidin to detect actin-rich podosomes. The typical sparse and discrete podosomes as-
sembled in control DCs (A, arrow in inset) was clearly altered in DCs plated on biomaterials
mostly resulting in larger and clustered podosomes (B-F, arrows in insets). Scale bar: 5
µm (2.5 µm for insets).
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Figure 3.15: Quantification of podosome formation in DCs plated on the biomaterials.
Each value corresponds to the mean of three independent experiments. Among biomaterials,
PET induced the highest rate of the podosome formation in DCs in contrast to LT706 with
minimal increase (almost 3%) relative to control cells.
The tendency of podosomes to form clusters was also evident in DCs plated
on RG503. In this case, however, the podosomes had a fuzzy appearance (Fig-
ure 3.14F, arrow in inset). These morphological alterations also corresponded
to changes in the number of podosomes, which was higher in DCs plated on
PET (Figure 3.15).
Chapter 4
Discussion
4.1 Biocompatibility of polymers
Biocompatibility is a major concern to be taken into account when designing
and manufacturing new medical implants. Under ideal conditions, implants
should not affect cell’s biological features such as viability, division and dif-
ferentiation.
The International Standardization Organization (ISO) provides guidelines
for the biological evaluation of medical devices. According to ISO 10993-1 a
panel of in vitro and in vivo tests relevant to the safety of the biomaterials
has to be carried out to determine the degree of biocompatibility of a novel
material.
At this stage, it must be pointed out that different cell types or cells
at different stages of their development sense and react to biomaterials in
different ways. An example of this differential behavior is offered by the
observation that PEA C induces death rate three times higher in immature
than in mature dendritic cells (this Ph.D. thesis). Conversely, this biomaterial
is well tolerated by murine fibroblast L929 cells (Hemmrich et al., 2008).
Lack of any cytotoxic effect as routinely tested is no guarantee for an
inert biomaterial behavior. For instance, applications in which stem cells are
differentiated under the support of a biopolymer, which per se do not cause
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appreciable cell death (i.e. is not cytotoxic), may be influenced by the ability
of the biomaterial to interfere with the differentiation process (Otto et al.,
1996). In this context, cytotoxicity tests done with the same biomaterial
library used in this Ph.D. work clearly indicate that biomaterials can affect
cell viability, proliferation and differentiation to an extent that depends on
cell type and species (Neuss et al., 2008).
Furthermore, the biodegradable character of biomaterials differentially in-
fluences the differentiation of human monocytes (Dinnes et al., 2008), whereas
cell types as diverse as macrophages and fibroblasts have different adhesion
capability toward Teflon (Godek et al., 2004). Collectively, this Ph.D. work
and the above studies highlight the need for cell type- and function-specific
assays during the evaluation of novel biopolymers.
4.2 Response of DCs to biomaterials
In this study, it has been clearly demonstrated that non-toxic biomaterials
profoundly alter the phenotype and function of DCs. The reactivity of these
cells to biomaterials has different magnitudes being stronger against alginate,
LT706 and RG503 and weaker toward PDLLA, PDMS and PET.
Consistent with these findings, it has been showed that PLGA, a polymer
chemically related to RG503, induces the up- regulation of surface markers
and inflammatory cytokines in both murine and human DCs (Yoshida et al.,
2006; Yoshida et al., 2007). Moreover, the exposure of human DCs to NiCl2
and heptane DNCB (dinitirochlorobenzene) increases the expression of CD86,
CD56 and MHC II and the secretion of IL-1β, IL-6 and TNFα (Aiba et al.,
1997).
81
In addition, alginate is also a potent stimulator of murine macrophages, in-
ducing in these cells the secretion of high levels of IL-1β, IL-6, TNFα and
IL-12 in a NF-κB dependent manner (Yang and Jones, 2009). This biomate-
rial also increases the phagocytic activity, the up regulation of CD80 as well
as the production of H2O2 and NO in murine peritoneal macrophages (Son et
al., 2001; Pasquali et al., 2005).
Conversely, another study using human DCs showed that alginate has an
inert behavior toward these cells (Babensee and Paranjpe, 2005). Although
the reasons for this discrepancy are not known, it is conceivable that the source
of alginate and the cell type may have caused these contrasting outcomes. The
influence of cell type on these kind of studies is clearly demonstrated by the
observation that NiCl2 and MnCl2, which are frequently used in alloy-based
implants, up-regulate MHC II, CD86 and TNFα expression in DCs, whereas
they have no effect on macrophages (Manome et al., 1999).
In contrast to alginate, LT706 and RG503, the biopolymers PDMS, PET
and PDLLA were poorly reactive toward DCs. Safety of silicone implants and
its effect on immune system has been a matter of controversy. There have
been studies on the chronic inflammatory response to silicone, which might
lead to autoimmune diseases or tumorigenecity (Bar-Meir et al., 2003; Tugwell
et al., 2001; Brinton et al., 2004; McLaughlin et al., 1998; Brinton, 2007).
In vivo studies of Prantl et al. confirm the weak reactive nature of PDMS
that I have observed in vitro. In the context of chronic inflammation, they
investigated the distribution pattern of peripheral blood lymphocyte subsets
34±11 months after silicone breast implantation. They found no sign of sys-
tematic inflammatory reactions in these patients in comparison to control
individuals, although, they did not investigate the local inflammatory effect
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of implants shortly after implantation (Prantl et al., 2008). The authors be-
lieve that the chronic reactions mentioned above are probably due to the fact
that even if the implant does not rupture, small amounts of low weight silicone
might leach into the surrounding tissue and activate the cells residing locally.
On the other hand, Iribarren (Iribarren et al., 2002) reported a persistent re-
cruitment of cells to the injection site of fluid silicon over a period of 45 days.
Inconsistency between the outcomes of these observations might be due to
the fact the scope and intensity of post-implantation inflammatory response
alters by time and as a further matter, biomaterials in the solid and fluid
states elicit different immune reactions.
Beamer’s investigations show that silica interferes with the ability of myel-
oid-derived DCs to appropriately respond to LPS, CpG or poly I:C by down-
regulating MHC II, CD40, CD56 and CD86. There are evidences that silica
predispose individuals to bacterial infection (Beamer et al., 2008). I observed
the same inhibitory effect when DCs were exposed to PDLLA which did not
respond to secondary LPS stimulation. The molecular mechanism of the sup-
pressive effect of the PDLLA remains to be further investigated.
Although some biomaterials did not profoundly influence the activation
status of iDCs, some of them occasionally up-regulated one or few surface
markers and cytokines. For instance, in agreement with Ding et al., (2007), I
also observed that PTFE increased the secretion level of IL-1β and the TNFα.
Marques et al., (2004) showed that in vitro incubation of PLLA could activate
human blood lymphocytes and macrophages and results in increased secretion
of IL-6, IL-1β and TNFα. Similarly, I also observed that PLLA induced more
than 20 times the secretion of IL-1β and mildly stimulated the secretion of
IL-6 and TNFα as compared to control untreated DCs.
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My and other observations prove that biomaterials, based on their physico-
chemical characteristics, elicit a broad range of immune response in the cells.
These biological reactions must be considered in selecting the proper bioma-
terial in the context of the desired application.
One of the most important characteristics of DCs is their ability to activate
antigen-specific naïve T cells. Thus, the above-mentioned biomaterial-induced
alterations may also have an influence on this DC function. Indeed, this study
has demonstrated that there is a direct relationship between the magnitude of
the up-regulation of surface markers and cytokines and the ability of DCs to
activate T cells. Particularly, biomaterials that induced a robust up-regulation
of surface markers and cytokines such as alginate, LT706 and RG503 conferred
on DCs a strong ability to activate naïve CD4+ T cells. Similarly, weaker DC
“activators”, such as PDLLA and PDMS, conferred on these cells modest T-cell
activation properties.
It has been well demonstrated that T cells play an important role in pro-
moting foreign body reactions either by recruiting other immune cells to the
implantation site or by mediating macrophage fusion (McNally et al., 1996;
Kao et al., 1995). Additional observations indicate that chemicals and poly-
mers (i.e. CaCl2, NiCl2, DNCB and chitosan) directly stimulate or suppress
T-cell proliferation (Aiba et al., 1997; Porporatto et al.,2009; Schuster et al.,
2001). Taken together, these studies and this Ph.D. work highlight the im-
portance of understanding how biopolymers affect the function of immune
cells.
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4.3 Pattern recognition receptors and response
to biopolymers
4.3.1 TLR/MyD88-mediated DC response
It is well known that proteins of the TLR family are widely involved in sensing
microorganism-derived molecular structures and DC activation (Ishii et al.,
2008). Since DCs exposed to biomaterials acquire an active phenotype, it is
likely that TLRs mediate DC-biomaterial interactions.
In fact, by using DCs lacking MyD88−/− or single TLRs, this study clearly
showed that biomaterials affect DCs function primarily via TLR4, TLR2 and
TLR6 in a MyD88-dependent manner. These observations are consistent with
the study of Flo et al. who showed that TLR2 and TLR4 mediate the acti-
vation of macrophages by alginate (Flo et al., 2002) and that blocking TLR4
signalling inhibits the immune response against alginate (Flo et al., 2002;
Iwamoto et al.,2005). TLR2 and TLR4 (and TLR1) have been implicated
in the inflammatory response induced by hydroxyapatite particles, oxidised
alkane polymers, chitin and oxidants including H2O2 and cigarette smoke ex-
tract (CSE) (Grandjeen-Laquerrire et al., 2007; Da Silva et al., 2008; Maitra et
al., 2008; Paul-Clarck et al., 2009). Moreover, it has been shown an increase
of the expression of TLR2, 4, 5, 9 in monocytes and macrophages residing
around total hip joint in the aseptic loosening of these implants (Tamaki et
al., 2009).
Thus, sensing of biomaterials through TLR/MyD88 signaling pathways
may represent a general mechanism by which immune cells react to implants.
Since TLRs can sense the hydrophobic portion of biological molecules as an
alarm signal (Seong and Matzinger, 2004), it is possible that the reaction of
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DCs to biomaterials may be caused by the recognition of hydrophobic amino
acids sequences within adsorbed proteins.
In this context, biomaterials, such as PDLLA and PET, are generally
hydrophobic. Thus, the hydrophobic character of biomaterials may be rec-
ognized by TLRs as a danger signal and contribute to the alteration of DC
function. Consistent with this idea is the observation that hydrophobic bioma-
terials induce a greater amount of cytokines and chemokines in macrophages
and DCs than hydrophilic/ionic counterparts (Jones et al., 2006; Shankar et
al., 2010).
In addition, as the immune system can generate antibodies against im-
planted biomaterials (Goldblum et al., 1992; Ziegler et al., 1994; Pastor et
al., 2001; Zippel et al., 2001; Schlosser et al., 2002; Wilhelm et al., 2007), it
is also possible that the interaction of TLRs with biomaterials involves the
direct recognition of biomaterial surface.
Regarding some degradable biomaterials, preliminary experiments in the
course of this study showed that in the absence of the endosomal TLR7 and
TLR9, DCs exposed to alginate, LT706, PDLLA and RG503 generate lower
amounts of RANTES and TNFα suggesting that degradation or hydrolytic
products may be responsible for the reaction of DCs to degradable biopoly-
mers.
4.3.2 Non-TLRs and sensing biomaterials
Particles or biomaterial debris at micron and nano scale can be internalized by
cells. Recent investigations have revealed the involvement of NALPs, members
of the pattern recognition receptor family NLRs, in sensing and responding
to such foreign particles. Phagocytosis of such small particles usually leads to
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the damage of the lysosomal compartment resulting in stimulation of NALP3
and the consequent activation of caspase 1 and the secretion of IL-1β and
IL-18 (Maitra et al., 2009). The activation of NALP3 by different particulate
vaccine adjuvant for instance alum, chitosan, aluminium phosphate, calcium
phosphate, PLG and LPS-coated PLGA has been demonstrated in several
investigations (Sharp et al., 2009; Li et al., 2008; Demento et al., 2009; Eisen-
barth et al., 2008).
Since the exposure of DCs to biomaterials induces high levels of IL-1β,
NALP3 can be hypothetically involved in the response of these cells to degrad-
able biomaterials. This possibility is supported by pilot experiments (data
not shown), showing that the overall response of NALP3−/−and ASC−/− (a
component of the NLR signaling cascade) DCs to PDLLA was reduced in
comparison to WT cells.
4.4 The role of serum protein and direct contact
in DC-biomaterial interactions
Current view of the initial stage of host-implant interactions involves the ad-
sorption of fibrinogen on the surface of the biomaterial. The adsorption pro-
cess leads to alteration of fibrinogen conformation and makes the P1 (γ 190-
220) and P2 (γ 377-395) fragments of its D domain available for the phagocyte
membrane proteins complement receptor 3 (CR3) and Mac-1 (CD11b/CD18).
The engagement of these receptors induces the secretion of IL-1β and TNFα,
which attract other immune cells to the implantation site thus initiating a
local immune reaction (Luttikhuizen et al., 2006; Hu et al., 2001; Tang and
Eaton, 1993; Tang and Hu 2005).
Although widely accepted, this view is challenged by the observation that
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the host immune system can generate implant-specific antibodies (Goldblum
et al., 1992; Ziegler et al., 1994; Pastor et al., 2001; Zippel et al., 2001;
Schlosser et al., 2002; Wilhelm et al., 2007), suggesting that immune cells can
also “see” the uncoated surface of the biomaterial.
In this Ph.D work, the expression of surface markers induced by bioma-
terials in serum-free media was not grossly affected, although the levels of
the mRNAs for some of the cytokines analyzed were lower when serum was
omitted from the culture. Similar results were achieved in a study, which
demonstrated that in the absence of serum, PLLA does not stimulate the se-
cretion of IL-6, IL-12 and TNFα in the macrophages (Chomyszyn-Gajewska
et al., 2002).
Moreover, in the absence of fibrinogen the accumulation of phagocytes
around implanted PET disks is reduced (Hu et al., 2001; Tang and Eaton,
1993). Thus, though these data further support a role for adsorbed serum
proteins in the recognition of biomaterials, the fact that DCs respond less
efficiently to LPS, suggest that the lower secretion of cytokines in DCs stimu-
lated with biomaterials may be attributed to less reactive status of these cells
rather than to the lack of a proteinaceous coat around the biomaterials.
Another factor to be taken into account for the analysis of biomaterial-
cell interactions is the biodegradability of the biopolymer. In this study,
it was found that in the absence of a physical contact between DCs and
degradable biomaterials the up-regulation of surface markers and cytokines
was diminished but not completely abolished. These data suggest that, at
least for this kind of biomaterials, the function of these cells can be influenced
by a combination of physical contact and release of soluble products.
Although it was not possible to indentify the soluble products respon-
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sible for altering DC phenotype, particular attention must be paid to the
potential immunogenicity of the degradation products. In this context, it
has been shown that degradation products of PLLA with a low molecular
weight (80kDa) have immunogenic properties, whereas high molecular weight
degradation products (321 kDa) do not elicit any immune response (Lincoff et
al., 1997). Scheibner and Termeer also demonstrated that low MW hyaluro-
nan can be recognized as danger signal by TLR2 and activate dendritic cells
whereas high MW hyaluronan did not exhibit this capacity (Scheibner et al.,
2006; Termeer et al., 2000).
Finally, it should be pointed out that degradation of biomaterials could
be favorable when gradual release of drugs or antigens is desired. An example
of such application is provided by the beneficial use of PDLLA degradation
process for local drug and antibiotic delivery that can minimize the side effects
caused by systemic drug administration (Vogt et al., 2004; Gollwitzer et al.,
2003).
4.5 Biomaterial-mediated podosome formation
in dendritic cells
Interaction between host and implant initiates with cell adhesion on implant’s
surface. Such event depends not only on the type of cells recruited to the
implantation site, but also on biomaterial physico-chemical features including
topography, hydrophobicity and total charge.
For instance, it has been shown that cell attachment on hydrophobic bio-
materials, like PLGA and PET, is higher than that to hydrophilic surfaces
(Babensee and Paranjpe 2005; Chang et al., 2009; Sevastianov, 2002). Actin
cytoskeleton remodeling plays a crucial role in the adhesion and motility of
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several immune cells (Krause et al., 2000; Coppolino et al., 2001; Sechi and
Wehland, 2004).
In DCs, podosomes, actin-rich adhesive structures typical of DCs and other
immune cells, are disassembled following the engagement of TLRs, such as
TLR4 (van Helden et al., 2006; West et al., 2004). Moreover, in TLR4−/−
mice the number of macrophages recruited to PET implantation site is reduced
(Rogers et al. 2010) further establishing a link between TLR signaling and cell
motility and adhesion. Given the role of TLR/MyD88 signalling pathways in
DC-biomaterial interactions, it is therefore not surprising that the adhesion
of these cells and, in particular, their ability to form podosomes is affected by
the biomaterials.
Although this study could not provide a link between chemical and phys-
ical properties of the biopolymers and their effect on podosome formation, it
is clear that given the role of podosomes in the regulation of DC adhesion and
motility (van Helden et al., 2006; Calle et al., 2006; Spurrell et al., 2009), the
data presented here suggest that biomaterials alter also this DC functional
property. In future studies, biomaterial-dependent alterations of podosomes
can be exploited to understand how podosome-mediated DC adhesion influ-
ences the motility and, hence, the immune properties of these cells.
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4.6 Concluding remarks
Biomaterials are routinely used in different medical related applications. Daily
thousands biomaterials are implanted in the body of patients as a part of their
treatment. These achievements have opened new doors of hope to help pa-
tients suffering from organ failure and offer more specific and efficient vaccine
and drug delivery strategies. Despite these important achievements, immune
reactions against implanted foreign material remains the main challenge in
the biomaterial field.
This work shows that DCs sense chemically and physically diverse biomed-
ical polymers through a general mechanism, which involves multiple TLR-
dependent signaling pathways. The specific engagement of TLRs by these
polymers is sufficient to induce in DCs an active phenotype and alter their ad-
hesive properties. These findings, in combination with immuno-bioengineering
studies on structure-function analyses, could be useful for designing biomate-
rials that are more bioinert or that activate specific immune receptors, thus
leading to desired immune responses.
Given the major role of TLR2, TLR4 and TLR6 in the alteration of DC
functions by biomaterials shown here, I envisage the possibility to design
biomaterials that specifically activate TLR2 or TLR4 to achieve an antigen-
specific TH1- or TH2-type immune response, respectively. Consistent with
this idea, maturation of DCs and TLR3-triggered immune response using
poly(I:C)-coated PLGA particles has been reported (Wischke et al., 2009).
In this context, Chen et. al. (2010) have used some cationic polymers to
promote a TLR4-mediated TH1-type immune response.
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Figure 5.1: Chemical name and medical applications of the biomaterials used in this
study.
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Figure 5.2: Chemical formula of the biomaterials used in this study.
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Figure 5.3: Technical data of the RT-PCR primers used for cytokine quantification.
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Figure 5.4: Statistical analysis of the surface markers expression in biomaterial-treated
wild type DCs.*
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Figure 5.5: Statistical analysis of the surface markers expression in biomaterial-treated
MyD88 KO DCs.*
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Figure 5.6: Weight changes after 24 h, 48 h, and 72 h.
Figure 5.7: Weight changes after 24 h, 48 h, and 72 h.
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Figure 5.8: pH values of the PBS after 24 h, 48 h, and 72 h incubation of biomaterial
compared to the reference pH values of PBS 7.17.
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Figure 5.9: FTIR spectra of incubation solution of Alginate in PBS after one and three
days and intact PBS solution.
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Figure 5.10: FTIR spectra of incubation solution of PDLLA in PBS after three days and
intact PBS solution.
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Abbreviations
APCs Antigen presenting cells
APC-labeled Allophycocyanin-labeled
ASC Apoptosis-associated speck-like protein
BC Before christ
BM-DC Bone-Marrow derived dendritic cell
BMPC Bone marrow progenitor cell
BSA Bovine serum albumin
C3 Complement component 3
C3d Complement component 3 fragment d
CB Cytoskeleton buffer
CCL Chemokine ligand
CCR Chemokine receptor
CD Cluster of differentiation
cDC Conventional dendritic cell
cDNA Complementary deoxyribonucleic acid
CDP Common DC precursor
CFSE Carboxyfluoroscein succinimidyl ester
CpG Cytosine (unmethylated)-phosphate-guanosine
CR3 Complement receptor 3
CSE Cigarette smoke extract
DAPI 4′,6-Diamidino-2-phenylindole dihydrochloride
DC Dendritic cell
DC-LAMP Denndritic cell lysosome-associated membrane protein
DC-STAMP Dendritic cell specific transmembrane protein
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DEAE-dextran Diethylaminoethyl-dextran
dL/g Deciliter per gram (unit of intrinsic viscosity of polymers)
DNA Deoxyribonucleic acid
DNCB Dinitirochlorobenzene
dNTPs Deoxynucleotide triphosphates
dsRNA Double stranded ribonucleic acid
EGTA Ethylene glycol tetraacetic acid
FAs Focal adhesions
FACS Fluorescence-activated cell sorting
F-actin Filamentous actin
FBC Foreign body capsule
FBGC Foreign body giant cells
Fc Fragment crystallizable
FCS Fetal calf serum
FITC Fluorescein isothiocyanate isomer
FLt-3L Fms-like tyrosine kinase 3 ligand
g Earth’s gravitational acceleration
FTIR Fourier transform infrared
GM-CSF Murine granulocyte-macrophage colony stimulating
HA Hydroxyapatite
huIGF-1 Human Insulin-like growth factor
Hyper IL-6 IL-6/IL-6R fusion protein
iDC Immature dendritic cell
IFA Incomplete Freund’s adjuvant
IFNγ Interferon gamma
IgG Immunoglobulin G
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IL Interleukin
IRF Interferon regulatory factor
ISO International standardization organization
kDa Kilo dalton
KO Knockout
LAL Limulus amebocyte lysate
LCs Langerhans cells
LDH Lactate dehydrogenase
LPS Lipopolysaccharide
LRR Leucine-rich repeat
LSM Lymphocyte separation medium
MACS Magnetic-activated cell sorting
mDC Mature dendritic cell
MDP Macrophage-dendritic cell progenitors
MHC I/II Major histocompatibility complex I/II
µg Microgram
mRNA Messenger ribonucleic acid
MW Molecular weight
muSCF Murine colony stimulating factor
MyD88 Myeloid differentiation primary response gene (88)
NALP NACHT,LRR- and pyrin
NF-κB Nuclear factor kappa-B
ng Nanogram
NLR (NOD)-like receptors
NOD Nucleotide-binding and oligomerization domain
OVAII Ovalbumin II
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PAMP Pathogen-associated molecular pattern
PBS Phosphate buffered saline
PCL Poly(e-caprolactone)
PCR Polymerase chain reaction
pDC Plasmocytoid dendritic cell
PDCA-1 Plasmacytoid DC Ag-1
PDLLA Poly(D,L-lactic acid)
PDMS Poly(dimethyl siloxane)
PE Polyethylene
PE-conjugated R-Phycoerythrin-conjugated
PEA C Polyesteramide type C
PEG Polyethyleneglycol
PEI Poly(ethylenimine)
PET Poly(ethylene terephthalate)
PEU Polyether urethanes
PFA Paraformaldehyde
pg Pico gram
PI Propidium iodide
PIPES 1,4-Piperazinediethanesulfonic acid
PLG poly (lactide-co-glycolide)
PLGA poly(lactic-co-glycolic acid)
PLL Poly-L-Lysin
PLLA Poly(L-lactic acid)
Poly(I:C) Polyinosinic:polycytidylic acid
PRRs Pattern recognition receptors
PTFE Poly(tetrafluoroethylene)
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PVDF Poly(vinylidene fluoride)
RANTES Regulated on activation normal T cell expressed and secreted
RLH (RIG)-I like helicase
RNA Ribonucleic acid
RNS Reactive nitrogen species
ROS Reactive oxygen species
ROIs Reactive oxygen intermediates
rpm Round per minute
RPMI Royal park memorial institute (culture medium)
RT Room temperature
RT-PCR Real time-polymerase chain reaction
Siglec-H Sialic acid binding Ig-like lectin-H
TGFβ Transforming growth factor beta
TIR Toll/Interlekin-1 receptor
TH1/2 T helper cell response type 1/2
TLR Toll like receptor
TNFα Tumor necrosis factor alpha
TRIF TIR-domain-containing adapter-inducing Interferon
U/mL Unit per milliliter
UHMWPE Ultra high molecular weight polyethylene
UV Ultra violet
WT Wild type
w/o Without
v/v Volume/volume
VIS Visible
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